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Introduction
Osteoporosis is a highly diffuse disease that typically affects
elderly individuals. It is a metabolic and systemic skeletal disease cha-
racterized by low bone mineral density (BMD), micro-architectural dete-
rioration of the bone tissue and by an increase in bone porosity, leading
to bone fragility and increased susceptibility to fracture. In recent years,
substantial progress has been made in the identification, prevention, and
treatment of osteoporosis, primarily with the aim of reducing fractures,
the main cause of osteoporosis-related morbidity.
The World Health Organization suggests to use dual energy
x-ray absorptiometry (DXA) to provide a quantitative definition of os-
teoporosis [1]. As a consequence it is the most widely used method of
BMD assessment. The loss of bone mineral in the human skeleton, due
to metabolic changes, affects primarily the micro-architectural structure
of spongy bone. For this reason investigations on skeletal sites with
high trabecular content such as spine, proximal femur and calcaneus
are recommended for early diagnosis of osteoporosis. Although DXA
examination is cheap, it is known to have a limited sensitivity. Quan-
titative computed tomography, or QCT, is a more accurate technique
because it measures the true volumetric density, rather than providing
an area-adjusted result as does DXA. As a consequence, QCT may be
useful in assessing response to therapy in the cancellous bone and in the
prediction of fracture risk. However, it involves appreciable radiation
exposure, making QCT less suitable for regular treatment monitoring
particularly in young patients, and deterring normal control subjects
from participating in clinical trials. Nevertheless, only a poor correla-
tion between BMD assessments and the relative risk of bone fracture has
been reported [2,3], suggesting that other factors besides low BMD likely
contribute to determine bone fragility. This lack of information on bone
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fracture risk, which is critical for clinical purposes, has prompted intense
research to identify new parameters with the ability to assess spongy-
bone status and to provide reliable measures of bones resistance.
Magnetic resonance imaging (MRI) was initially appeared un-
suitable for assessing bone, due to a rapidly decaying signal of the solid
crystalline structure. Due to its peculiarity, MRI was right from the
start widely used in functional and morphological clinical assessment of
the brain tissue. For this reason, cerebral tissue is better characterized in
terms of NMR parameters with respect to the musculoskeletal system.
Although bone contains approximately 15% water at various binding
stages (primarily interstitial and collagen-bound water), its relaxation
properties (T1 of 250-300 milliseconds and T2 of 250 microseconds) yield
it difficult to detect. However, marrow, whether it is hematopoietic or
fatty, has the usual properties of water or fatty acid triglyceride protons
characteristic of soft tissue and thus can easily be detected and imaged.
Hence, the bone marrow signal, contrasting with the virtual background
constituted by the bone, generates an ideal environment for imagebased
assessment of trabecular architecture. At present, musculoskeletal imag-
ing is the fastest growing field in MR imaging after neuro-radiological
applications. This is mainly due to the demonstrated potentiality of
NMR methods for the evaluation of osteoporosis [4, 5]. Although MRI
provides no direct information on bone density, with the positive back-
ground given by all types of bone marrow, it provides a good resolution
of the internal structure of cancellous bone without any radiation dose.
Our choice to use NMR methods for osteoporosis assessment is due to
their ability to analyze the bone in all its components and properties:
by MR relaxometry of bone marrow, on the one hand, is possible to
obtain quantitative information about trabecular bone density and spa-
tial rearrangement of bone micro-architecture (this is the first effect of
osteoporosis, so it is very useful to study it for the early osteoporosis
diagnosis); by MR spectroscopy and water diffusion in bone marrow, on
the other hand, is possible to obtain information on the physiological
and functional changes joined in osteoporosis.
The absence in literature of a study on the best NMR osteoporosis in-
dex and the best heel spongy bone site to detect osteoporosis, induced
us to develop this work. We analyzed two heel spongy bone sites, the
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calcaneus and the talus. The choice of the heel was mainly due to three
reasons: the established correlation between vertebral body fracture and
poor trabecular bone density in calcaneus spongy bone [3,6,7], the high
heterogeneity of the trabecular bone network in calcaneus [8] and talus
and the negligible problems linked to claustrophobic symptoms.
We used a multiparametric approach to investigate heel spongy bone.
Specifically T ⋆2 , T2, ADC and Gi parameters and marrow fat content by
means of MRS were obtained and correlated each others.
The present thesis consists of three parts. In the first part
(Chapters 1, 2) the osteoporosis disease with its related fractures are
dealt by medical, biochemical and epidemiological knowledge, and the
methods by which to diagnose it are described and compared. The
second part (Chapter 3) proposes a review of the advanced NMR tech-
niques used in this work. In the last part (Chapters 4, 5, 6, 7) the
original experimental results, obtained in vivo in heel spongy bone of
healthy, osteopenic and osteoporotic subjects were reported. The whole
matter of this thesis is organized into seven chapters as follows.
Chapter 1 The disease and related fractures. This introductory chap-
ter describes the bone characteristics related to its morphology,
composition, physiology and marrow; it also explains the bone
mass-sex-age relation, identifies the determinants of peak bone
mass, the causes of bone loss and the risk factors for osteoporotic
fracture.
Chapter 2 Diagnosis of osteoporosis. This chapter is a short review
of the methods of measuring bone mass or density, of the BMD
thresholds for the classification of the persons as proposed by a
WHO Study Group, of the sites and techniques advised for the
diagnosis of osteoporosis and of the assessment of fracture risk.
Chapter 3 Used NMR techniques. In this chapter the main theoretical
concepts of MR spectroscopy and diffusion techniques and of few
used pulse sequences are explained.
Chapter 4 1H NMR Spectroscopy of bone marrow. Here the marrow
fat content (Mfc) and its correlation with T -score parameter and
age of the subjects is investigated in an anatomical region rich of
yellow marrow, such as the calcaneus.
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Chapter 5 Bone marrow diffusion. The bone marrow water MR Diffu-
sion and its correlation with T -score,Mfc and Age of the subjects
is investigated in calcaneus, in talus and in some their different re-
gions.
Chapter 6 Internal gradient. The potential ability of the internal gra-
dient (Gi) parameter to describe spongy bone status related to its
trabecular bone density and quality, is assessed by in vitro and in
vivo experiments in calf samples and in postmenopausal subjects
respectively. Gi parameter, but also the T
⋆
2 and T2 parameters
are investigated with their correlations with T -score, Mfc, ADC
and Age of the subjects, in calcaneus, in talus and in some their
different regions.
Chapter 7 The best Site-Parameter. Finally, the power of T ⋆2 , T2,
ADC, Gi and Mfc NMR parameters to discriminate among nor-
mal, osteopenic and osteoporotic persons is underlined in this
chapter. Indeed, the best parameter and the best heel spongy
bone site, by which to obtain the best discrimination, are indi-
cated. Moreover, the site-parameter couples which best classify
the subjects in the same way of T -score, are identified.
Osteoporosis
5

Chapter 1
The disease and related
fractures
Until recently, osteoporosis was an under-recognized disease
and considered an inevitable consequence of ageing; perceptions have
changed, as epidemiological studies have highlighted the high burden
of the disease and its costs to society and health care systems and this
trend will be worse in the future because of the mean age increases and
so the elderly person number increases.
Osteoporosis is an established and well-defined disease that affects more
than 75 million people in Europe, Japan and the USA, and causes more
than 2.3 million fractures annually in Europe. It does not only cause
fractures, it also causes people to become bedridden with secondary com-
plications and also causes back pain and loss of height, so prevention
of the disease and its associated fractures is essential for maintaining
health, quality of life, and independence among the elderly.
This systemic skeletal disease is characterized by low bone density and
microarchitectural deterioration of bone tissue with a consequent in-
crease in bone fragility; early osteoporosis is not usually diagnosed and
remains asymptomatic, it does not become clinically evident until frac-
tures occur. Loss of bone density occurs with advancing age and rates
of fracture increase markedly with age.
Osteoporosis is three times more common in women than in men, partly
because women have a lower peak bone mass and partly because of the
hormonal changes that occur at the menopause. In addition, women live
longer than men and therefore have greater reductions in bone mass.
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Men lose 15-45% of cancellous bone and 5-15% of cortical bone with ad-
vancing age, whereas women lose 35-50% of cancellous bone and 25-30%
of cortical bone [9].
The most serious osteoporotic fracture is that of the hip which typically
results from fall, but some occur spontaneously; women are more often
affected than men and the incidence rates rise exponentially with age.
Overall, 90% of hip fractures occur among people aged 50 years and
over, and 80% occur in women. The average age at which osteoporotic
hip fractures occur is about 80 years in developed countries but is less in
countries with lower life expectancies. Hip fractures are usually painful
and most of them heal, but with a high degree of morbidity and appre-
ciable mortality, depending in part on the patient’s age, the treatment
given and associated morbidity; the mean hospital stay is 30 days.
Identifying the incidence of vertebral fractures may be difficult because
many are asymptomatic or cause too few symptoms to provoke inves-
tigation, so rarely lead to hospitalization. They may occur with osteo-
porosis or with other diseases; the incidence is greater among women
than among men and increase with age but less than that observed for
hip fractures.
Forearm fractures are common among the middle-aged and elderly and
are generally caused by a fall; the incidence in women increases markedly
within 5 years of the menopause, reaches a peak between the ages of 60
and 70 years and levels off thereafter. They are rarely fatal and seldom
require hospitalization [1].
1.1 Bone characteristics
1.1.1 Morphology
The bones of the adult skeleton comprise two types of tissue,
cortical or compact, and cancellous or spongy bone. Most bones con-
sist of an outer cortical sheath enclosing a porous trabecular network
of cancellous bone that houses the marrow. The trabecular network
consists of connecting rods and plates. An important characteristic of
trabecular bone is the volume fraction of bone BVF that is the ratio
of volume occupied by bone to the volume occupied by bone and mar-
row. Trabecular bone with a low BVF is typified by an open network
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of rods with more isolated islands of trabeculae and more branches that
terminate without connecting to another branch (rod-like structure); in-
stead a high BVF means fewer open spaces (plate-like structure). The
rods and plates are preferentially oriented along the lines of mechanical
strain of the bone. This structure maximizes strength while minimizing
weight. In the adults, 80% of the skeleton is cortical bone, however,
the relative proportions of cortical and cancellous bone vary in different
parts of the skeleton.
In the long bones, like femur and humerus, the diaphysis is a hollow
Figure 1.1: Longitudinal section of long bone [10]. 1, epiphysis (spongy
bone); 2, diaphysis (compact bone); 3, morrow channel of diaphysis; 4,
hole of a nutritive channel.
cylinder of compact bone which preserves the marrow channel (see Fig.
1.1); only the inner layer which borders the marrow is constituted by
spongy bone. By means of metaphysis, diaphysis is connected in the
extremities with epiphysis. Epiphysis and the most of short bones like
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Figure 1.2: Section of dried femur which shows his compact and spongy
tissue; the femur’s head is covered by a thin layer of articular cartilage
AC [11].
calcaneus, are constituted by spongy bone covered by a compact bone
thin layer (see Fig. 1.2). In the growth, epiphysis and diaphysis are
separated by the so called conjugation cartilage or epiphysial disk ; the
transition region between epiphysial disk and diaphysis is metaphysis
which is the growth region, in fact when the conjugation cartilage ossi-
fies, the longitudinal growth of the bone stops.
The long bones are covered by a vascularized connective fibrous-elastic
thin layer, the periosteum. The morrow channel of diaphysis and those
of spongy bone are covered by a thin layer of plate cells, the endosteum.
1.1.2 Composition
The bone tissue is composed by cells and by an organic and an
inorganic intercellular matrix.
The mineral component of bone (inorganic matrix ) accounts for about
65% of its total dry weight and it is predominantly hydroxyapatite
(Ca10(OH)2(PO4)6) but also carbonates, citrate, magnesium, sodium,
fluoride and strontium.
The organic matrix accounts for approximately 35% of the total dry
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weight of bone; approximately 90% of this matrix consists of bone-
specific collagen, the remainder consists of non-collagenous proteins.
The matrix proteins are synthesized and laid down by osteoblasts. Col-
lagen fibres are usually oriented in a preferential direction, giving rise to
a typical lamellar structure (see Fig. 1.3). The lamellae are generally
parallel to each other if deposited along a flat surface such as the surface
of the trabecular network or the periosteum, or concentric if synthesized
within cortical bone on a surface that borders a channel centered on a
blood vessel like the longitudinal haversian channels. These concen-
tric structures within cortical bone are known as osteons or haversian
systems [12]. The cortical bone is also crossed by perpendicular and
oblique Volkmann’s channels which are joined with haversian channels,
periosteum, endosteum and bone lacunae in which there are osteocytes.
Among these, only bone lacunae are in trabeculae. This interconnected
system allows the metabolic and gassy changes between the blood in
Havers and Volkmann’s channels (in compact bone) or in marrow chan-
nel (in spongy bone) and osteocytes.
The bone hardness and rigidity depend on the mineral component of
Figure 1.3: Three dimensional picture of diaphysis segment [10].
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bone while the traction and pressure resistance on collagen fibres. The
plasma concentration and/or the urinary excretion of collagen products
and certain non-collagenous proteins reflect the rate of bone formation
and resorption [13] and are used clinically as biochemical markers of
bone turnover.
The bone cells are osteoblasts, osteocytes and osteoclasts.
• Osteoblasts are bone-forming cells. They originate from local mes-
enchymal stem cells (bone marrow stroma or connective tissue
mesenchyme), which undergo proliferation and differentiate to pre-
osteoblasts and then to mature osteoblasts [14]. Preosteoblasts
tally on trabecular surface, in connective tissue of bone’s marrow
caves, in periosteum inner surface, in endosteum and they cover
Havers and Volkmann’s channels. The osteoblasts form a uni-
directional epithelial-like structure at the surface of the organic
matrix. The thickness of this layer, called osteoid, depends on the
time between matrix formation and its subsequent calcification
termed primary mineralization. Transport systems located in the
plasma membrane of osteoblasts are responsible for the transfer of
bone mineral ions, mainly calcium and phosphate, from the extra-
cellular space of the bone marrow to the osteoid layer [15]. The
plasma membrane of osteoblasts is rich in alkaline phosphatase,
which enters the systemic circulation. The plasma concentration
of this enzyme is used as a biochemical marker of bone formation.
Towards the end of the production of the bone matrix and the
deposition of mineral ions, the osteoblasts become either flat lin-
ing cells or osteocytes [16]. A slow process of mineral deposition,
by means of other osteoids (secondary mineralization), completes
the process of bone formation. At the end of the bone formation
process, in periosteum and endosteum remain some cells of mes-
enchymal origin which can differentiate to osteoblasts in replay to
appropriate stimulus as like as fractures.
• Osteocytes originate from osteoblasts embedded in the organic
bone matrix, which subsequently become mineralized. They have
numerous long cell processes forming a network of thin canaliculi
that connects bone lacunae, in which they are, with active os-
teoblasts and flat lining cells. Fluid from the extracellular space
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in the bone marrow circulates in this network. Osteocytes prob-
ably play a role in the homeostasis of this extracellular fluid and
in the local activation of bone formation and/or resorption in re-
sponse to mechanical loads.
Figure 1.4: Electronic microphotography of an osteoclast. The ruﬄed
border and the light area of the cellular surface are observable. The
bone calcified matrix near the ruﬄed border appears erose, while that
near the light area appears normal [10].Magnification 14.000 X
• Osteoclasts are giant cells containing 4−20 nuclei that resorb bone.
They originate from haematopoietic stem cells, probably of the
mononuclear/phagocytic lineage, and are found in contact with
the calcified bone surface within cavities called Howships lacunae
(also known as resorptive lacunae) that result from their resorptive
activity. Osteoclastic resorption takes place at the cell/bone inter-
face in a sealed-off microenvironment [17]. In this regard, the most
prominent ultrastructural feature of osteoclasts is the deep folding
of the plasma membrane, called the ruﬄed border (see Fig. 1.4), in
the area apposed to the bone matrix. This structure is surrounded
by a peripheral ring, called the light area, tightly adherent to the
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bone matrix, which seals off the subosteoclastic resorbing compart-
ment. The mechanism of bone resorption involves the secretion of
hydrogen ions and proteolytic enzymes into the sub-osteoclastic
resorbing compartment. The hydrogen ions acidify the extracel-
lular space (pH 4.5) and dissolve the bone minerals, thereby ex-
posing the organic matrix to the proteolytic enzymes [18]. These
enzymes are responsible for the breakdown of the organic matrix.
The process releases the minerals that contribute to calcium and
phosphate homeostasis. Accordingly, biochemical markers of colla-
gen degradation which are found in plasma and urine, can provide
estimates of the bone resorption rate.
1.1.3 Physiology
Both the shape and structure of bone are continuously reno-
vated and modified by the processes of modelling and remodelling.
• Bone modelling begins with the development of the skeleton dur-
ing fetal life and continues until the end of the second decade,
when the longitudinal growth of the skeleton is completed. In the
modelling process, bone is formed at locations that differ from the
sites of resorption, leading to a change in the shape or macroar-
chitecture of the skeleton. Bone modelling may continue, but to
a lesser extent, during adult life when resorption at the end en-
dosteal surface increases the mechanical strain on the remaining
cortical bone, leading to the stimulation of periosteal bone ap-
position. This phenomenon, which increases with ageing and is
somewhat more pronounced in men than in women, offsets in part
the negative effects of bone resorption at the endosteal surface on
mechanical strength.
There are two kinds of osteogenesis: intramembranous (or mes-
enchymal) and endochondral (or cartilagineal). The first is a direct
ossification in which bone directly forms on a primitive connective
tissue by differentiation of mesenchymal cells in osteoblasts. The
ossification process begins in so called ossification centers where
connective tissue mesenchyme condenses, its cells proliferate and
blood vessels form. At first, membranous bone is spongy and
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it is constituted by irregular trabeculae which border the primi-
tive spaces of marrow occupied by hematopoietic cells, osteogenic
cells and blood vessels. Where bone must be spongy, trabeculae
assume a more regular lamellar organization and the inserted con-
nective tissue becomes hematopoietic tissue. Where bone must be
compact, trabeculae continue to thicken, filling all or partly the
vascular spaces forming the Havers and Volkmann’s channels and
connective tissue which rings bone condenses in periosteum.
In the endochondral ossification, a cartilagineal model is replaced
all or partly by bone.
Osteogenesis of vertebral column, hip, limbs is a duplex process:
membranous ossification of periosteum and endochondral ossifica-
tion (see Fig. 1.5).
• Bone remodelling occurs simultaneously with modelling from fetal
life through to skeletal maturity, when it becomes the predominant
process that occurs throughout adult life. Remodelling maintains
the mechanical integrity of the skeleton by replacing old bone with
new. Bone resorption and bone formation occur at the same place,
so that there is no change in the shape of the bone. In the adult
skeleton, approximately 5−10% of the existing bone is replaced
every year through remodelling. This does not occur uniformly
throughout the skeleton, but in focal or discrete sites.
In both cortical and cancellous bone, the remodelling process be-
gins with bone resorption by osteoclasts. This phase is over within
a few days and is followed by the departure of multinucleated os-
teoclasts. Subsequently, mononuclear cells line the resorption la-
cunae and deposit a cement line marking the limit of prior erosion
and the newly formed bone. These mononuclear cells are subse-
quently replaced by osteoprogenitor cells, which differentiate into
cuboidalshaped osteoblasts. Organic matrix is then laid down,
followed by the deposition of minerals. The lacunae are gradu-
ally filled with new bone over several months. Thereafter, the
osteoblasts change shape and eventually become flattened lining
cells. In compact bone osteoclasts form resorption channels which
filled with bone become new osteons. The remodelling process is
controlled by systemic and locally produced cytokines [19]. The
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Figure 1.5: Schematization of the long bone growth [10]; cartilage is de-
picted in blue, calcified cartilage in violet, bone in black, blood vessels in
red. A, cartilagineal draft; B, formation of the periosteal bone muff; C,
beginning of the cartilage calcification in the center of diaphysis; D, E,
calcified cartilage is partly reabsorbed by chondroclasts, like osteoblasts,
with formation of cavities occupied by blood vessels and mesenchyme;
F, blood vessels and mesenchyme penetrate into cartilage of epiphysis,
trabeculae of calcified cartilage and their bone covering are reabsorbed
by chondroclasts and osteoclasts to form the first marrow channel draft
of diaphysis;G,H, ossification centers in superior and inferior epiphysis;
I, L, closures of inferior and superior epiphysis by means of ossification
of conjugation cartilage and presence of a thin layer of articular cartilage
in the extremities.
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maintenance of a normal, healthy, mechanically competent skele-
tal mass depends on keeping the process of bone resorption and
formation in balance. Failure to match bone formation with bone
resorption results in net bone loss. This is what occurs in osteo-
porosis.
Osteoclast formation is controlled by several circulating hor-
mones, including parathyroid hormone (calcitriol, an active metabolite
of vitamin D3), and the gonadal steroids, estrogen and testosterone [20].
The bone marrow also plays an essential role as a source of cytokines
such as tumor necrosis factors (TNFs) [21], which also regulate osteo-
clast formation and activity. These systemic and local factors regulate
osteoclast formation and activity in fact hormones and cytokines act
on the osteoblastic cells, which possess a cell surface molecule known
as RANK ligand (RANKL, formerly known as osteoclast differentiation
factor), and a cell surface false receptor, osteoprotegerin (OPG) [22]
(see Fig. 1.6). RANKL is a member of the TNF ligand family and
interacts with osteoclast precursors from the haematopoietic lineage
(macrophages). This interaction promotes the differentiation and fu-
sion of the osteoclast precursor, thus leading to the formation of mature
osteoclasts. Osteoprotegerin is a soluble member of the TNF receptor
superfamily that is produced by osteoblast cells and inhibits osteoclast
formation. Osteoblasts also secretes the macrophage colony stimulating
factor (M-CSF ), a cytokine which binds itself to c-fms receptor of the
osteoclast precursor.
About the mechanisms of hormone action, parathyroid hormone (PTH )
interacts with osteoblast and stimulates osteoclastogenesis increasing
RANKL and M-CSF productions and decreasing OPG production, cal-
citonin inhibits bone resorption by acting directly on mature osteoclasts,
bisphosphonates, which are used in treating osteoporosis, also inhibit
osteoclasts, probably by interfering with the system of communication
between osteoblasts and osteoclasts, but also reduce the number of os-
teoclasts by inhibiting either their recruitment or their survival, estrogen
and probably testosterone exert their effects on the bone resorption by
inhibiting the production of cytokines, particularly TNFs.
Several growth factors can stimulate the proliferation of osteoblasts
in vitro [23]. Their respective importance in vivo is not yet clear.
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MACROPHAGE
Figure 1.6: Osteoclastogenesis mechanism [10].
Nevertheless, it has been suggested that the production and action of
growth factors are vital to the stimulation of bone formation in response
to systemic hormones such as PTH, osteogenic agents and mechanical
strain [24].
Virtually all (99%) of the bodys calcium is located in bone and teeth.
Only 0.1% is in the extracellular compartment and the remainder is
within cells. The maintenance of a constant extracellular concentration
of ionized calcium (calcium homeostasis) is essential, because calcium
influences many physiological functions and biochemical pathways. The
extracellular concentration of calcium is regulated by a dynamic equilib-
rium between the levels calcium in the intestine, kidney and bone [25].
In young adults, the rates of calcium entering and leaving the extracellu-
lar compartment are equal. The urinary excretion of calcium represents
the difference between the amount filtered and that reabsorbed. In a
steady state, urinary calcium excretion corresponds roughly to the net
calcium fluxes entering the extracellular compartment from the intestine
and bone. In the kidney 98% of the calcium filtered by the glomerulus
is reabsorbed in the renal tubule. The major regulator of the intestinal
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absorption of calcium is calcitriol [26]. It is formed in the kidney, and
its production is controlled by PTH and the extracellular concentrations
of calcium and phosphate. The main regulator of the renal tubular re-
absorption of calcium is PTH, secretion of which is controlled by the
extracellular concentration of calcium [27].
1.1.4 The bone marrow
As one of the larger and more important organs in the human
body, bone marrow plays important physiologic roles in both health and
disease. In healthy individuals, its function is to provide a continual sup-
ply of red cells, platelets, and white cells to meet the body’s demands
for oxygenation, coagulation, and immunity. As such, bone marrow fre-
quently becomes a target, either directly or indirectly, of many varied
disease processes.
The basic microstructure of bone marrow consists of an osseous frame-
work housing fat cells and hematopoietic cells both supported by a sys-
tem of reticulum cells, nerves, and vascular sinusoids. Cellular con-
stituents of marrow include all stages of erythrocytic and leukocytic
development, as well as fat cells and reticulum cells [28]. Erythrocytic,
granulocytic, and megakaryocytic cell lines replenish the body’s supply
of red cells, white cells and platelets. The role of fat cells in marrow
function is unclear. Speculation suggests that fat cells provide surface
and nutritional support and possibly growth factors for hematopoiesis.
Reticulum cells consist of both phagocytic cells (macrophages) that play
a role in immunity and undifferentiated nonphagocytic cells whose role
is yet to be fully defined. In red marrow, these nonphagocytic reticulum
cells occur in greater abundance in perivascular locations and form a
reticular meshwork that provides nutritional and mechanical support to
the hematopoietic cells. These reticular cells appear to have the capac-
ity to accumulate lipid and transform into the fat cells of red and yellow
marrow.
The various components of normal marrow may be simplified into a
unifying concept-that of red and yellow marrow. That fraction of bone
marrow actively involved in the production of blood cells is termed
hematopoietic or red marrow. The remaining fraction, which is hema-
topoietically inactive, is termed yellow marrow. Important anatomic
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and compositional differences exist between these two types of marrow.
On average, the chemical composition of red marrow is approximately
40% water, 40% fat, and 20% protein. The cellular composition of red
marrow is 60% hematopoietic cells and 40% fat cells. Red marrow has a
rich, arborized vascular network. Yellow marrow’s chemical composition
is approximately 15% water, 80% fat, 5% protein. Its cellular composi-
tion is 95% fat cells and 5% nonfat cells. Physiologically, the fat cells in
yellow marrow are relatively stable, while those in red marrow appear
to be labile. Yellow marrow has a sparse vascular network.
At birth, virtually the entire marrow space contains red marrow. Dur-
ing growth and development, conversion of red to yellow marrow occurs
throughout the skeleton. This conversion begins in the immediate post-
natal period and is first evident in the terminal phalanges of the hands
and feet [29]. The process then progresses from peripheral (appendicu-
Figure 1.7: Adult pattern of red/yellow marrow. Usually by 25 years of
age, the primary conversion of red to yellow marrow has been accom-
plished and the adult distribution of red/yellow marrow established.
Red marrow is concentrated in the axial and proximal appendicular
skeleton while yellow marrow occupies the remainder of the appendicu-
lar skeleton.
lar) toward central (axial), with respect to the skeleton as a whole, and
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from diaphyseal to metaphyseal in individual long bones. Flat bones and
vertebral bodies show similar patterns. Although generally symmetric,
the rate and extent of conversion is not uniform but varies according to
site in a particular bone as well as among bones. Usually by 25 years
of age, the process of primary red marrow conversion to yellow marrow
is complete and a balanced distribution of red and yellow marrow has
been achieved [30]. This balance will vary from person to person as it
is influenced by at least age, gender, and health. Similarly, the balance
between red and yellow marrow achieved in individual bones varies by lo-
cation. Red marrow is predominately concentrated in the axial skeleton
(skull, vertebrae, ribs, sternum, and pelvis) and the proximal appen-
dicular skeleton (proximal femora and humeri) (see Fig. 1.7). Yellow
marrow dominates the remaining portion of the appendicular skeleton
and is variably admixed throughout the axial skeleton. Physiologic con-
version of red to yellow marrow continues after 25 years of age, albeit at
a slower pace and islands of hematopoietic tissue may be found in areas
dominated by fatty marrow and vice versa. The process of red to yellow
marrow conversion is, at times, halted or reversed as alterations in the
body’s demand for hematopoiesis provoke a reconversion of yellow mar-
row to red marrow. Thus, the process occurs first in the axial skeleton
followed by the appendicular skeleton in a proximal to distal sequence.
1.2 Peak bone mass and loss of bone
The peak bone mass is the amount of bone tissue present at
the end of skeletal maturation. It is a major determinant of the risk of
fracture due to osteoporosis since the mass of bone tissue at any time
during adult life is the difference between the amount accumulated at
maturity and that lost with ageing. There is, therefore, considerable
interest in exploring ways to increase peak bone mass.
1.2.1 Bone mass-sex-age relation
There is no evidence for sex differences in bone mass at birth.
This absence of a substantial sex difference in bone mass is maintained
until the onset of puberty [31]. The difference following puberty is cha-
racterized by a more prolonged period of bone maturation in males than
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in females, resulting in a greater increase in bone size and cortical thick-
ness but there is no significant sex difference in the volumetric trabecular
density at the end of puberty. There is also an asynchrony between the
gain in standing height and the growth of bone mineral mass during pu-
berty. This phenomenon may be responsible for the transient fragility
that may contribute to the higher incidence of fracture that occurs near
puberty. In adolescent girls, the gain in bone mineral density BMD
declines rapidly after menarche and is insignificant 2 years later. In
adolescent boys, the gain is particularly rapid between the ages of 13
and 17 years but declines markedly thereafter in all sites except the
lumbar spine and mid-femur, where growth continues until the age of
20 years. This suggests an important sex difference in the magnitude
and/or duration of the phase that contributes to the ultimate peak bone
mass. Bone mass does not change significantly between the third and
fifth decades. At the beginning of the third decade, there is a large
variability in the normal values of BMD [32], particularly at sites sus-
ceptible to osteoporotic fractures, such as the lumbar spine and femoral
neck. This variance is not substantially reduced by correction for stand-
ing height, and does not appear to increase significantly during adult
life.
1.2.2 Determinants of peak bone mass
Determinants of peak bone mass include heredity, sex, en-
docrine factors, dietary factors, mechanical forces and exposure to risk
factors.
• Heredity.
Studies suggest that genetic factors may account for up to 50% or
more of the variance in BMD values in the population [33]. The
contribution of genetic factors to bone mineral mass and density
is slightly less at the proximal femur and the forearm than at the
lumbar spine, suggesting that the impact of genetic (or genetic
and environmental factors) varies according to the skeletal site.
Genetic determinants appear to be expressed before puberty as
shown by correlation in BMD and bone size between prepubertal
daughters and their premenopausal mothers, a model in which half
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of the genes are common. The heritability of peak bone mass is
likely to be polygenic.
• Endocrine factors.
Various endocrine factors influence bone growth. The production
of these steroids increases before and during puberty, but the time-
course of their production does not match the accelerated gain in
bone mass. In contrast, calcitriol concentration and the tubular
reabsorption of inorganic phosphate rise with the accrual of bone
mass. This may be an adaptive response to the increased demand
for calcium and phosphate.
• External factors.
Modification of environmental factors can cause an individual to
change the track of bone accrual. Nutritional factors are particu-
larly important determinants of peak bone mass and rate of gain
of bone mass. The amount of calcium and protein in the diet
modulate the gain in bone mass and calcium supplementation sig-
nificantly enhances the rate of BMD in children and adolescents.
Various disorders impair the optimal acquisition of bone mass
during childhood and adolescence. In diseases such as anorexia ner-
vosa and exercise-associated amenorrhoea, malnutrition, sex steroid de-
ficiency and other factors combine to increase the risk of osteopenia
or low bone mass. This is probably also the case for various chronic
diseases, which in addition may require therapies that affect bone me-
tabolism.
Delayed puberty is defined as the absence of any sign of puberty at the
attainment of the upper normal limit of chronological age for its on-
set [34]. Epidemiological studies have provided indirect evidence that
late menarche decreases peak bone mass and is a risk factor for osteo-
porosis. In addition, osteopenia has been reported in a cohort of men
with a history of delayed puberty. The onset of puberty is a complex
process involving the activation of endocrine systems of which the tar-
gets include factors influencing the bone mineral balance and the growth
rate of the skeleton.
Significant deficits in both cancellous and cortical bone are observed in
young adult women with chronic anorexia nervosa, and may be severe
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enough to result in osteoporotic fractures.
The acquisition of bone mass may be impaired when women with hy-
pogonadism and low body weight engage in intensive physical activity
exercise-associated amenorrhoea. Intensive training during childhood
may contribute to the later onset and completion of puberty.
1.2.3 Loss of bone
The onset of substantial bone loss is usually around age 65
years in men and 50 years in women. There is little variation in bone
size throughout life, beyond continuous, slight expansion of the outer
dimensions. The expansion of the periosteal surface is less than the
increase in space occupied by the bone marrow which results from a
greater resorption at the endosteal surface. Under these conditions, the
bone cortex becomes thinner. This process, together with increasing
porosity of cortical bone and destruction of trabeculae through thin-
ning and perforation, accounts for age-dependent bone loss.
Estrogen is necessary, not only for maximizing peak bone mass in men
and women, but also for maintaining it. It controls bone remodelling
in reproductively active women and in ageing men. Estrogen deficiency
accelerates the rate of bone turnover, thereby altering the balance be-
tween bone formation and bone resorption, and appears to be the main
cause of osteoporosis in women after the fifth decade, and possibly in
men.
Among the other endocrine causes of bone loss, primary hyperparathy-
roidism and hyperthyroidism increase the rate of bone turnover, thereby
inducing bone loss [35]. In contrast, excess glucocorticoids reduce bone
formation. In addition, administration of glucocorticoids in pharma-
cological excess may decrease the intestinal absorption of calcium and
possibly also its reabsorption by the renal tubules. These latter two
effects would lead to a negative calcium balance and result in increased
bone resorption.
Among nutritional factors that cause bone loss, deficiencies in calcium,
vitamin D [36], and protein [37] have been shown to be associated with
deficient skeletal growth or accelerated bone loss. In the elderly, several
factors contribute to negative calcium balance. With ageing, calcium
intake decreases because of reduced consumption of dairy products, and
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the absorptive capacity of the intestinal epithelium to adapt to low cal-
cium intake is impaired. The capacity of the renal tubule to reabsorb
calcium, and its responsiveness to PTH are impaired. Exposure to sun-
light and the capacity of the skin to produce vitamin D are also reduced
in the elderly; severe and prolonged deficiency of vitamin D results in
rickets in children and osteomalacia in adults, conditions characterized
by defective mineralization of bone, osteomalacia will aggravate osteo-
porosis, since both increase the risk of fracture. Vitamin D deficiency
is rare in Europe and the USA, but is still common in the Middle East
and the Asian subcontinent. Increasing calcium intake is certainly an
important strategy which is relatively easier to implement than other
possible preventive measures. Low protein intake is an important de-
terminant of peak bone mass and therefore of the risk of osteoporosis
in later life; protein replenishment in patients with hip fracture can im-
prove not only BMD, but also muscle mass and strength. Dietary intake
of phosphates may be increasing in some populations as a result of their
use as food additives and the increase in intake of carbonated drinks.
These drinks may have a deleterious effect on bone, because they have
replaced milk in the diet of some young people, and because high intakes
of phosphates stimulate the secretion of PTH, but there is no evidence
so far that high phosphate intakes accelerate bone loss in humans.
1.2.4 Risk factors for osteoporotic fracture
Osteoporosis is characterized by low bone mass which may be
the consequence of development of the skeleton during adolescence (low
peak bone mass) and/or excessive bone loss thereafter. Its clinical and
social consequences, however, are the result mainly of the associated
fractures. Lifetime fracture risk depends both on fracture incidence of
a kind of bone and life expectancy (see Table 1.1). These two factors
are different among countries. Fracture rates is in fact highest in North
America and Europe, particularly in Scandinavia [38]. The risk of os-
teoporotic fractures is instead lower in Africa and Asia. Any structural
engineer knows that the static and dynamic strength of a structure is a
function of the materials intrinsic properties, the amount of material per
unit volume (apparent density), and its spatial arrangement. Bone is
a composite material that must obey the same fundamental principles.
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Fracture site
Lifetime risk of fracture (%) (95% CI)
Women Men
Proximal femur 17.5 (16.8− 18.2) 6.0 (5.6− 6.5)
Vertebra (a) 15.6 (14.8− 16.3) 5.0 (4.6− 5.4)
Distal forearm 16.0 (15.7− 16.7) 2.5 (2.2− 3.1)
Any of the above 39.7 (38.7− 40.6) 13.1 (12.4 − 13.7)
CI, confidence interval.
(a) Clinically diagnosed fractures.
Table 1.1: Estimated lifetime risk of fracture in Caucasian men and
women at age 50 years in Rochester, MN, USA [9].
It is generally agreed that around 60% of the bones mechanical compe-
tence typically can be explained by variations in the apparent density
(bone mass/tissue volume). The remainder is likely due to other pa-
rameters related to bone quality. So, in addition to bone mass, other
skeletal components also influence bone strength, including both the
macro- and microarchitecture of bone and the degree of mineralization
of the matrix as well as the crystal characteristics [39]. In cortical bone,
mechanical strength is affected by the histological structure, including
the presence of primary versus osteonal bone, the orientation of the
collagen fibres, the number and orientation of the cement lines, and the
presence of microdamage. In cancellous bone, mechanical strength is af-
fected by the microstructural arrangement of the trabeculae, including
their orientation, connectivity, thickness, and numbers. The macro- and
microarchitectural components of bone strength could explain, at least
in part, clinical observations that variations in bone mineral mass are
not closely correlated with changes in fracture rate. Throughout most
of adult life, aging bones become more structurally efficient and retain
their strength even though BMD declines. They get larger with thinner
cortical walls, thus maintaining strength despite BMD loss. The homeo-
static mechanism for strength maintenance depends on skeletal loading.
Thus, to maintain bone strength, normal loading on the skeletal system
must be maintained. Absence of loading during prolonged spaceflight
can cause uncompensated loss of bone strength.
The risk of fragility fractures also depends on several extraskeletal fac-
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tors. A fracture is a structural failure of the bone that occurs when
the forces applied to it exceed its load-bearing capacity. Thus, inde-
pendently of the size, geometry and physical properties of the bone, the
direction and magnitude of the applied load will determine whether a
bone will fracture in a given situation. Falls are the most common cause
of traumatic osteoporotic fractures, but the mechanics of falling are such
that only about 5% of falls lead to a fractures. The occurrence of one
osteoporotic fracture may also increase the risk of future fractures [40].
About genetics, up to 50% of the variance in peak bone mass and some
aspects of bone architecture and geometry relevant to bone strength
may be determined genetically [41].
As previously said, dietary factors influence peak bone mass, age-related
bone loss but also fracture risk. Calcium and vitamin D are particularly
important since deficiencies are potentially correctable.
Immobility is an important cause of bone loss, in contrast, bone density
increases in response to physical loading and mechanical stress.
Cigarette smoking reduces BMD as a result of the consequent earlier
menopause, reduced body weight and enhanced metabolic breakdown
of exogenous estrogen in women [42].
Studies of people dependent on alcohol have suggested that high levels
of alcohol consumption may be detrimental to bone, however, moder-
ate consumption of alcohol has not consistently been associated with
increased risk of fracture or reduced bone density. In postmenopausal
women, alcohol consumption appears to reduce both bone loss at the
hip and the risk of vertebral fracture [42].
Low body mass index (BMI) is associated with lower peak bone mass,
and an adverse influence on bone loss. This may be the consequence of
reduced peripheral estrogen production by adipose tissue and metabolic
influences on body composition. Accelerated weight loss is also an im-
portant determinant of the risk of hip fracture.
Primary hypogonadism in both sexes is associated with low bone mass,
and decline in estrogen production at the menopause is the most impor-
tant factor contributing to osteoporosis in later life. Late menarche may
be associated with lower peak bone mass and higher fracture risk. The
use of oral contraceptives may be associated with higher bone mass. A
premature menopause is a strong determinant of bone density and in-
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creased risk of fracture.
An increased risk of osteoporosis is associated with a host of other dis-
eases and disorders, including endocrine and metabolic disorders, and
malignant disease, and with the use of certain drugs.
So, hormonal therapy, physical exercise and calcium and vitamin D in-
takes can limit the bone loss but not necessarily bone returns to its
previous condition.
Chapter 2
Diagnosis of osteoporosis
The internationally agreed description of osteoporosis is that
it is a systemic skeletal disease characterized by low bone mass and mi-
croarchitectural deterioration of bone tissue, with a consequent increase
in bone fragility and susceptibility to fracture. This view of osteoporosis
embodies the concept that bone mass is an important factor in the risk
of fracture, but that other skeletal abnormalities contribute to skeletal
fragility, while some non-skeletal factors also affect fracture risk. The
assessment of fracture risk should therefore encompass all these factors.
2.1 Methods of measuring bone mass or density
The bone mass of a particular part of the skeleton is directly
dependent on both the volume or size of the part concerned and the
content of the mineralized tissue contained within its periosteal enve-
lope (bone mineral content BMC in gram of hydroxyapatite). The mean
volumetric mineral density of bony tissue (volumetric BMD in gram of
hydroxyapatite per cm3) can be determined by quantitative computed
tomography (QCT ). The areal or surface BMD (in gram of hydrox-
yapatite per cm2) can be determined by single- or dual-energy X-ray
absorptiometry (SXA and DXA). There are also other methods of mea-
suring bone mass or density like quantitative ultrasound QUS, radiogra-
phy and nuclear magnetic resonance NMR. The last one it will discuss
in the next chapters. The values generated by these techniques are di-
rectly dependent on both the size and integrated mineral density of the
scanned skeletal tissue. The integrated mineral density is determined
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by cortical thickness, the number and thickness of the trabeculae, and
the true mineral density corresponding to the amount of hydroxyapatite
per unit volume of the bone organic matrix.
• Single- and dual-energy X-ray absorptiometry (SXA and DXA).
Single and dual X-ray absorptiometry (SXA, DXA) are methods
of assessing the mineral content of the whole skeleton, as well as
of specific sites, including those most vulnerable to fracture. The
term bone mineral content BMC describes the amount of mineral
in the specific bone site scanned, from which a value for BMD
can be derived by dividing the bone mineral content by the area
or volume measured. With both SXA and DXA this is an areal
density rather than a true volumetric density, since the scan is
two-dimensional, as illustrated in Fig. 2.1.
In single-energy absorptiometry, bone mineral is measured at
Figure 2.1: Two-dimensional DXA scan of the lumbar spine and hip in
a young healthy adult [1].
appendicular sites, such as the heel or wrist. Dual-energy absorp-
tiometry measures bone mineral at sites such as the spine and hip
and it can also measure total body bone mineral; SXA cannot be
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used for these sites. DXA is also being increasingly used for mea-
surements at appendicular sites.
Of the many techniques developed to assess bone mass, bone min-
eral or other related aspects of skeletal mass or structure, the
most highly developed technically and the most thoroughly vali-
dated biologically is DXA, which is regarded as the gold standard
and is used for the diagnosis of osteoporosis, prognosis (fracture
prediction), monitoring the natural history of the disorder, and
assessing response to treatment. The WHO classification of os-
teoporosis was based on DXA measurement of BMD at central
sites and forearm. DXA scans are commonly used because of their
high precision and accuracy, ability to measure bone density at
clinically relevant sites (i.e., hip and vertebrae), and modest radi-
ation exposure. The major disadvantages are that the machines
are expensive, not portable, and no widely available. DXA uses
two x-ray beams of different energy levels to scan the region of
interest and measure the attenuation as the beam passes through
the bone. Low-energy beams experience greater attenuation than
high-energy beams, and bone attenuates x-rays more than soft
tissue. Based on this discrepancy, corrections for soft tissue can
be made, which are particularly important due to the individual
variability in soft tissue content around the hip and spine.
The mathematical theory of DXA (referred to as basis set decom-
position) holds that the X-ray transmission factor through any
physical object can be decomposed into the equivalent areal den-
sities of any two designed materials [43]. For DXA scans, the two
materials chosen are hydroxyapatite and soft tissue. It follows that
DXA scan results will only accurately reflect the true BMD if the
object being examined is made up solely of the two chosen mate-
rials. In practice, for the purpose of describing the transmission of
X-rays the human body is made up of not two but three types of
tissue, namely bone, lean tissue and fat. Neglecting the difference
between lean and fat can cause errors in DXA measurements with
misrepresentation of the patient’s true bone status when BMD re-
sults are interpreted in terms of T-scores (see section 2.2); Blake
estimated that an increase in marrow fat content from 0 to 100%
32 Chapter 2: Diagnosis of osteoporosis
caused the measured BMD to decrease by 0.14 g/cm2 (1.3 T-score
units) in women and 0.16 g/cm2 (1.3 T-score units) in men [44].
• Quantitative computed tomography (QCT).
QCT is based on the differential absorption of ionizing radiation
by calcified tissue. Conventional whole body CT scanners, which
typically generate density information in terms of Hounsfield units,
need to be transformed to convert their results into units relevant
to BMD, then attenuation measurements are compared with a
standard reference to calculate bone mineral equivalents; for spine
QCT, the patient is usually scanned simultaneously with a calibra-
tion phantom for automatic standardization. Quantitative com-
puted tomography (QCT) has been applied both to the appendic-
ular skeleton and to the spine (see Fig. 2.2). Dedicated equipment
for assessing density at peripheral sites (pQCT) is widely used in
Europe. The major advantage of QCT in the assessment of cancel-
lous bone density, as compared with DXA, is that it measures true
volumetric density, rather than providing an area-adjusted result
as does DXA and this may be useful in assessing response to ther-
apy in the cancellous bone and in the prediction of fracture risk.
Its major disadvantages are high radiation exposure, difficulties
with quality control, high cost and less precision compared with
DXA, it is also less available than all the other methods. Recent
advances in imaging technology, notably micro-computed tomog-
raphy (µCT) and micro-magnetic resonance imaging (µMRI), offer
an opportunity to test the hypothesis that architecture is an in-
dependent contributor to bone strength. They give complexity
measurements that concern the bone three-dimensional structural
composition like spatial dynamics, local inhomogeneities of tra-
becular network, structural complexity (interstratification), tra-
becular disorders and organization of marrow space for µCT. In
vivo, however, dose limitations and point-spread function (PSF)
blurring of x-ray based tomographic methods severely limit the
achievable resolution even at peripheral anatomic sites; in fact
it is possible to acquire images at a voxel size of 165 x 165 x 165
µm3 although the width of the beam-size limited PSF is about 280
µm [5]. Unfortunately, this resolution is generally not sufficient to
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Figure 2.2: QCT scan of the lumbar spine. Vertebrae L1, L2, L3 are
indicated.
resolve trabecular elements without excessive partial volume blur-
ring.
• Radiography.
Osteoporosis can often be diagnosed by visual inspection (radio-
graphic morphometry) of plain radiographs. In addition, some
quantitative techniques may be useful in assessing risk. The most
widely used is the estimate of the cortical width of the second,
third and fourth metacarpals. Since the size of tubular bones in-
creases with age, thinning of the cortex represents an increase in
net endocortical bone resorption. The ratio of the cortical width
to the total width is therefore commonly used indices. Another
technique is radiographic absorptiometry RA using an aluminum
step-wedge incorporated into the film, thus permitting an estimate
of areal density to be made. Common sites of assessment include
the metacarpals, the distal phalanges and the distal forearm. Both
absorptiometry and morphometry have been used for many years,
but their usefulness in assessing fracture risk is only now being
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validated in prospective studies. In recent years it has become
apparent that vertebral deformity is a very strong risk factor for
subsequent fractures. There is, therefore, great interest in identi-
fying vertebral deformities due to osteoporosis that may not have
otherwise come to clinical attention.
• Quantitative ultrasound (QUS).
Quantitative ultrasound (QUS) has recently been used to assess
skeletal status in osteoporosis. The methods thoroughly evaluated
are broad-band ultrasound attenuation (BUA), which results from
scattering and absorption and speed of sound (SOS) (or ultrasound
velocity), which depends on elasticity and density. Because bone
(particularly cancellous bone) is inhomogeneous, ultrasound scat-
tering is complex. Attenuation in bone is determined by plotting
the linear relationship of the amplitude loss of the sound wave at
various frequencies. The slope of this line is referred to as the
broadband ultrasound attenuation (BUA). Attenuation is influ-
enced by both bone density and microarchitecture. These methods
have the advantage in that they do not involve ionizing radiation
and may provide information on the structural organization of
bone in addition to bone mass.
Figure 2.3: An ultrasound image using the UBIS 5000 and a standard
X-ray of the calcaneus [45].
QUS techniques cannot at the present time provide diagnostic criteria
for osteoporosis, but on current evidence they are suitable for the as-
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sessment of fracture risk in elderly women. Their use has been best
established for calcaneal systems. Its low cost and portability make
QUS more attractive for use in assessing the risk of fractures in larger
populations than may be appropriate for bone densitometry by X-ray
absorptiometry. Therefore, ultrasound assessment of bone density is ac-
ceptable for screening at-risk individuals with confirmation of the diag-
nosis by DXA. Ultrasound densitometry is not recommended to monitor
response to therapy because its sensitivity and confidence intervals are
too wide.
2.2 BMD thresholds
The most straightforward approach to the diagnosis of osteo-
porosis by bone density measurements is to define a threshold for BMD
that will encompass most patients with osteoporotic fractures. How-
ever, bone density measurements are also used to assess future risk of
fracture, so that more than one threshold will be needed.
Skeletal mass and density remain relatively constant once growth has
ceased, until approximately age 50 years in females and 65 years in
males. For every age, the distribution of BMC or BMD in healthy wo-
men is approximately normal irrespective of the measurement technique
used. Female individual bone density values are expressed in relation to
the distribution of BMD of a young female reference population, aged 50
years, in standard deviation units from the peak of distribution. This
reduces the effects of differences in calibration between instruments.
Standard deviation units used in relation to the young healthy popula-
tion of same ethnicity and sex are called T-scores. The following four
general diagnostic categories for women have been proposed by a WHO
Study Group based on measurements by DXA [9]:
• Normal.
A value of BMD within 1 standard deviation of the young adult
reference mean (T-score ≥ −1).
• Low bone mass (osteopenia).
A value of BMD more than 1 standard deviation below the young
adult mean, but less than 2 standard deviations below this value
(−2.5 < T-score < −1).
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• Osteoporosis.
A value of BMD 2.5 standard deviations or more below the young
adult mean (T-score ≤ −2.5).
• Severe osteoporosis (established osteoporosis).
A value of BMD 2.5 standard deviations or more below the young
adult mean in the presence of one or more fragility fractures.
Figure 2.4: Distribution of BMD in young healthy women aged 50 years
[1].
In women, bone loss occurs predominantly after the menopause.
In the young healthy population, because the distribution of bone den-
sity is normal, approximately 15% of the population have a T-score of
−1 or lower (low bone mass or osteopenia) and about 0.6% of the pop-
ulation have a T-score of −2.5 or less (osteoporosis)(see Fig. 2.4).
Since the distribution of BMD in the population is normal at all ages, the
proportion of women affected by osteoporosis at any one site increases
markedly with age in the same way as fracture risk increases with age
(see Fig. 2.5). The proportion of patients with osteoporosis increases
approximately exponentially with age and is in line with the increasing
incidence of many osteoporotic fractures among ageing women.
The Z-score is the number of standard deviations above or below
what’s normally expected for someone of same age, sex and ethnic or
racial origin (see Fig. 2.6). This is helpful because it may suggest have
a secondary form of osteoporosis through which something other than
aging is causing abnormal bone loss. A Z-score less than −1.5 might
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Figure 2.5: Distribution of BMD in women at different ages, and the
prevalence of osteoporosis [1].
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Figure 2.6: Interpreting T-scores and Z-scores. The T-score compares
bone density of a skeletal site of a patient with that of an average healthy
young adult of same ethnicity and sex. So if T-score is −2.0, bone den-
sity is lower than average by two standard deviations. The Z-score, on
the other hand, tells us how bone mass of a patient compares with that
of someone age, ethnicity and sex. So if Z-score is −0.5, bone density
is less than the norm for people same age by one-half of a standard
deviation.
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indicate these other factors are to blame.
Diagnostic cut-off values for men are not well established. However,
population studies and a prospective study have both suggested that
the cut-off value for spine or hip BMD used in women, i.e. 2.5 standard
deviations or more below the average, can be used for the diagnosis
of osteoporosis in men since the risks of hip and vertebral fractures are
similar in men and women for any given BMD [46]. This threshold value
may require adjustment for body size in some populations.
2.3 Sites and techniques
T-scores obtained by different techniques and at different sites
cannot be used interchangeably. A gold standard for diagnosis should
therefore be based on a particular site and technology. Measurements
of T-scores at the hip are the best predictors of hip fracture and the
hip is the site of greatest biological and clinical relevance, since hip frac-
ture is the dominant complication of osteoporosis in terms of morbidity
and cost. The T-score measured at the hip with DXA therefore pro-
vides the best diagnostic criteria. The selection of a standardized site
and technology for diagnosis does not preclude a valuable role for other
techniques in the assessment of fracture risk.
The ability of DXA and of other techniques to provide a diagnosis of
osteoporosis depends critically on their performance characteristics (see
Table 2.1). In the diagnostic use of these techniques, precision or re-
producibility is the degree to which further measurements will show the
same or similar results, accuracy is the degree to which a given test
measures BMD correctly; the accuracy of DXA at the hip exceeds 90%.
Residual errors arise for a variety of reasons, related to the technique
itself and the manner in which the technique is applied. For example,
standard DXA techniques use a two-dimensional projection and do not,
therefore, measure BMD (g/cm3), but rather areal density (g/cm2).
Thus, the size of the bone affects the apparent density since the rela-
tionship between area and volume is non-linear. Systematic inaccuracies
with DXA occur particularly at the spine since the vertebrae are irreg-
ular in shape and apparent density. This systematic error in measured
BMD when different machines are used can be partially avoided by us-
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ing T-scores. Non-systematic errors of accuracy also occur, the largest
source of error arises because of variable soft tissue density. The sources
of error in the diagnosis of osteoporosis by means of DXA are multi-
plex. Thus osteomalacia, a complication of poor nutrition in the elderly,
causes bone mass to be underestimated, extreme obesity and overlying
metal objects cause bone mass to be overestimated; osteoarthritis at the
spine or the hip is common in the elderly, and contributes to the density
measurement but not necessarily to skeletal strength; heterogeneity of
density due to osteoarthrosis or previous fracture can often be detected
on the scan and sometimes excluded from the analysis. Some of these
problems can be overcome with adequately trained staff and rigorous
quality control.
The WHO diagnostic classification cannot be applied to T-scores from
measurements other than DXA at the femur neck, total femur, lum-
bar spine, or one-third distal (33%) radius because those T-scores are
not equivalent to T-scores derived by DXA. The exclusive applicability
of the WHO diagnostic classification to DXA is inherent in the defini-
tion. Thus, the absence of an equivalent classification for techniques
other than DXA does not indicate problems of these techniques but
a deficiency of the WHO classification. This limitation is historically
understandable, since at the time of the formation of the WHO classi-
fication appropriate epidemiological data were only available for DXA.
At the spine, for example, T-scores measured with QCT are lower than
those measured with DXA. Equivalent values of T-score thresholds may
be defined for spinal QCT using the concept of comparable sensitivity
and specificity to discriminate vertebral fractures: a DXA T-score of
−2.5 would correspond to an equivalent QCT T-score of −3.3 [47].
2.4 Assessment of fracture risk
Osteoporosis is clinically significant as a predictor of fractures,
and it is for this reason that BMD measurements are of such great inter-
est. Studies with DXA indicate that the age-adjusted relative increase
in risk of fracture (the gradient of risk) approximately doubles for each
standard deviation decrease in BMD [48]. The diagnosis of osteoporosis
is based on a value for BMD below a cut-off threshold, but there is no
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Technique Site Cancellous Precision Accuracy Effective
bone (%) error error dose
in vivo (%) in vivo (%) equivalent
(µSv)
SXA Forearm - distal 5 1− 2 2− 5 < 1
Forearm ultradistal 40 1− 2 2− 5 < 1
Heel 95 1− 2 2− 5 < 1
DXA Lumbar - AP 50 1− 1.5 5− 8 1
Lumbar - lateral 90 2− 3 5− 10 3
Proximal - femur 40 1.5− 3 5− 8 1
Forearm 5 1 5 < 1
Total body 20 1 3 3
pDXA Forearm 5 1− 2 4− 6 ?
Calcaneus 95 1− 2 4− 6 ?
QCT Spine - trabecular 100 2− 4 5− 15 50
Spine - integral 75 2− 4 4− 8 50
pQCT Radius - trabecular 100 1− 2 ? 1
Radius - total 40 1− 2 2− 8 1
QUS: SOS Calcaneus/tibia 95/0 0.3− 1.2 ? 0
QUS: BUA Calcaneus 95 1.3− 3.8 ? 0
Table 2.1: Performance characteristics of various techniques of bone
mass measurement at various sites [9]. SXA, single x-ray absorptiome-
try; DXA, dual x-ray absorptiometry; QCT, quantitative computed to-
mography; QUS, quantitative ultrasound; BUA, broad-band ultrasound
attenuation; SOS, speed of sound; p, dedicated equipment for assessing
density at peripheral sites.
42 Chapter 2: Diagnosis of osteoporosis
absolute threshold of BMD that discriminates absolutely between those
who will or will not fracture. Normal BMD does not in itself guarantee
that fracture will not occur, only that the risk is decreased.
The gradient of risk depends on the used technique, on the measured
site and on the fracture typology. In general, site-specific measurements
show the higher gradients of risk for their respective sites. For example,
measurements at the hip predict hip fracture with greater power than
do measurements at the heel, lumbar spine or forearm [48]. However,
measurement of BMD by absorptiometric techniques at more than one
site improves the prediction of fractures. Gradients of risk range from
1.5 to 3.0 for each standard deviation decrease BMD. The choice of site
for assessment will depend both on the reason for the assessment and
on the age of the patient. Since hip fracture is the major concern in the
elderly, measurement at that site is preferable since such measurements
predict hip fractures most accurately. Thus, measurements made at the
wrist, heel, spine or hip may be useful in younger individuals.
Biochemical markers of bone turnover may be divided into two groups,
namely markers of bone resorption and markers of bone formation. Fast-
ing urinary calcium excretion (calcium/creatinine ratio) provides a net
index of the balance between bone resorption and formation. While
breakdown markers may change within 1 or 2 months of starting a
bone treatment, several months of treatment are required before any
significant change in formation markers becomes apparent. Since BMD
changes even more slowly, the rapid changes in markers induced by
treatment may be useful in selecting treatment, motivating patients,
and monitoring response to treatment (after four to six weeks of ther-
apy). These changes are insufficiently discriminatory, however, to pro-
vide a diagnostic test for osteoporosis but are of great value in assessing
fracture risk.
Nuclear Magnetic
Resonance
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Nuclear magnetic resonance (NMR) provides chemical and phy-
sical peculiarities of a system, analyzing its response to a perturbation.
In NMR this perturbation is constituted by electromagnetic waves with
frequency corresponding to the separation among energy levels of the
magnetic system (resonance).
Unlike the other techniques, NMR is able to get information from an
under-ensemble of a complex system, tuning in to a select nucleus, pro-
vided with spin angular momentum. It determines the total density of
a molecule of interest, its structure and dynamics, its interaction with
environment, the nature of chemical bonds, etc.. In NMR we can dis-
tinguish two important branches of study, magnetic resonance imaging
(MRI), it is able to provide NMR parameters for any select volume and,
for example in medicine, to point out pathological tissues, while to diag-
nose their pathological nature it needs magnetic resonance spectroscopy
(MRS) in vivo which analyzes the structural and biochemical aspects
of tissues. MRI is an emission rather than a transmission technique
where the signal arises from the sample or patient. Problems such as
parallax and focus that can and do occur in optical and X-ray methods
are inherently small in MRI. A Unlike other emission approaches, such
as positron emission tomography or single photon emission computed
tomography, the MR signal is intrinsic to the sample or tissue. A MR
contrast is based on tissue properties largely at the chemical and bio-
chemical level. The human eye is a remarkable instrument, capable of
resolving separations of 0.1 mm; like X-ray tomography, conventional
MRI has a spatial resolution coarser than that of the human eye with
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volume elements of order (1 mm)3; unlike X-ray CT however, where
resolution is limited by the beam collimation, MRI can also achieve a
resolution considerably finer than of 0.1 mm (MRI microscopy) by using
magnetic fields with frequencies in the interval of Ultra High Frequen-
cies, (300− 3000) MHz instead of High Frequencies, (3-30) MHz. While
it has yet to achieve the resolving power of the optical microscope (about
10 µm), it is non invasive, allowing slices of sample to be examined with-
out physical cutting and without use ionizing radiations.
On the other hand, the magnetic resonance signal from biological sam-
ples is relatively weak, resulting in three major consequences: relatively
powerful magnets are needed to achieve adequate signal, therefore, the
cost of the MR instrument, particularly the magnet, is high; MR instru-
ments are large and difficult to site, due to the large fringe magnetic
fields they are potentially hazardous; imaging times are generally long,
as the signal must be integrated over long periods to compensate for
its small amplitude. Furthermore, the MR signal from tissue is both
transient, lasting only a few tens of milliseconds, and refractory, tenths
of seconds to seconds are required for the signal to recover adequately
for repeated sampling.
Among the various and useful advanced NMR techniques, in this chap-
ter the attention will be focused on two branches evermore objects of
study for their considerable investigative potentialities and applied in
our experiments, the spectroscopy and diffusion.
By a fast description, the main theoretic concepts of these techniques
and of few used pulse sequences will be explained, to understand our
work that it will be discussed in the last chapters.
3.1 In vivo magnetic resonance spectroscopy MRS
Magnetic resonance spectroscopy has been applied in vivo from
the early beginnings of NMR, although dedicated techniques for in vivo
MRS were not developed until the 1970. In vivo MRS has provided a
wealth of non-invasive, spectroscopic information on, for instance, en-
ergy metabolism, amino acids, intracellular pH and reaction fluxes. It
has been used both as a fundamental research technique, as well as a
diagnostic tool in medical research.
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Following a RF pulse which is calibrated to rotate the equilibrium mag-
netization ~M0 by 90
◦, the magnetization precesses about the applied
external magnetic field ~B0 and induces an electromotive force (emf) in
a receiving coil positioned in the transverse plane. Because of T ⋆2 re-
laxation, the transverse magnetization and consequently the emf will
decrease as a function of time. The time-dependence of the emf (or
signal intensity) is called the free induction decay (FID). NMR spec-
trometers separately detect the x′ and y′ components of the complex
motion of the transverse magnetization (see Fig. 3.1):
~Mx(t) = ~M0 sin[(ω0 − ω)t+ φ]e−t/T ⋆2 ,
~My(t) = ~M0 cos[(ω0 − ω)t+ φ]e−t/T ⋆2 ,
(3.1)
where φ is the phase at t = 0.
Figure 3.1: The free induction decay of nuclear magnetization follow-
ing an excitation pulse. The complex three-dimensional FID can be
described completely by two projections on the (Mx, t) and (My, t)
planes, corresponding to the imaginary and real components of the FID,
respectively.
~Mx(t) and ~My(t) are normally referred to as the imaginary and real
FIDs, respectively. Although the FIDs hold all the relevant information
about the nuclear spins, like their resonance frequencies and relative
abundance, they are seldom used directly. Normally the time-domain
data (i.e. the FID) is converted to frequency-domain (i.e. the spec-
trum) by a Fourier transformation [49]. In principle it is possible to
construct a spectrum from one of the components of the complex FID,
therefore, both components are measured, using so-called quadrature de-
tection [50]. Fourier transformation of the time domain signals yields
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the real and imaginary frequency domain signals given by:
R(ω) = A(ω) cosφ−D(ω) sinφ
I(ω) = A(ω) sin φ+D(ω) cos φ,
(3.2)
where
A(ω) =
M0T
⋆
2
1 + (ω0 − ω)2(T ⋆2 )2
D(ω) =
M0T
⋆
2 (ω0 − ω)
1 + (ω0 − ω)2(T ⋆2 )2
.
(3.3)
A(ω) and D(ω) describe the absorption and dispersion components
of a Lorentzian lineshape and are drawn in Fig. 3.2A. The width at
half height, ∆ν 1
2
, of the absorption component of a Lorentzian line-
shape equals (πT ⋆2 )
−1. The dispersive component is broader, with a net
integrated intensity of zero. Therefore, for the best separation (or reso-
lution) of multiple lines in a NMR spectrum, absorption mode spectra
are desired. Pure absorption mode spectra can be obtained by phasing
the observed, mixed R(ω) and I(ω) spectra according to
A(ω) = R(ω) cos(φ− φc) + I(ω) sin(φ− φc)
D(ω) = −R(ω) sin(φ− φc) + I(ω) cos(φ− φc).
(3.4)
By interactive adjustment of the phase φc, absorption mode spectra are
obtained when φc = φ (see Fig. 3.2C). When the phase of the signal
is not relevant, or if the phase cannot be adjusted, the signal can be
presented in absolute value (or magnitude) mode (see Fig. 3.2D):
M(ω) =
√
(R(ω)2 + I(ω)2. (3.5)
The resonance frequency of a nucleus not only depends on the gyromag-
netic ratio and the external magnetic field, but is also highly sensitive to
its chemical environment; this is commonly referred to as the chemical
shift. The phenomenon of chemical shift is caused by shielding of nuclei
from the external magnetic field by electrons surrounding them. When
placed in an external magnetic field, the electrons will rotate about ~B0
in an opposite sense to the proton spin precession. Since this preces-
sion of electrons involves motion of charge, there will be an associated
electron magnetic moment which opposes the primary applied magnetic
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Figure 3.2: Principal components of a NMR spectrum. (A) Complex
Fourier transformation of a FID gives rise to Lorentzian absorption and
dispersion lineshapes. (B) In general, the initial phase of the FID is
non-zero, such that a mixture of absorption and dispersion lineshapes is
obtained. The dispersive component can be eliminated by phasing the
spectrum, such that only the absorption component remains as shown in
(C). From the phased spectrum, the frequency ν, the signal height h and
linewidth at half height ∆ν 1
2
can be accurately measured. (D) Phase
information is completely eliminated when presenting the spectrum in
magnitude mode; because the dispersive component is included, the
resonance is broader than the pure absorption lineshape.
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field ~B0, therefore the electrons will reduce the magnetic field that is
sensed by the nucleus, in electronic diamagnetism condition. This effect
can be expressed in terms of an effective magnetic field ~B at the nucleus,
~B = ~B0(1− σ) (3.6)
where σ is the shielding constant, a dimensionless number which de-
pends on the chemical environment of the nucleus, in fact, it increases
if electronegativity of the bound atom decreases. So, the resonance con-
dition will be:
ν = (
γ
2π
)B0(1− σ). (3.7)
NMR is, in principle, a quantitative technique, i.e. the signal inten-
sity generated by a certain class of nuclei is linearly proportional to
their number in the sample (and consequently the concentration). From
equations 3.1 it can be seen that the first point of the FID (t = 0), is
proportional to the total number of spins M0. However, after Fourier
transformation this quantity is convolved with the T ⋆2 . Therefore, the
peak height cannot be directly used for quantification (only in the rare
case when the T ⋆2 of all the resonances in the spectrum are identical).
However, the total peak area of a particular chemical bond is an accu-
rate measure for the spin density with that kind of bond and can be
obtained by (numerical) integration.
Most often chemical shifts are not expressed in units of Hertz but in
terms of (dimensionless) parts per million (ppm). According to conven-
tion, the chemical shift δ is defined as
δ =
νs − νref
νref
× 106 (3.8)
where νs and νref are the frequencies of the compound under investiga-
tion and a reference compound, respectively. The reference compound
should ideally be chemically inert and its chemical shift should be in-
dependent of external variables and should produce a strong (singlet)
resonance signal well separated from all other resonances. A widely ac-
cepted reference compound for 1H and 13C NMR is tetramethylsilane
(TMS) to which δ = 0 has been assigned. However, the use of TMS is
restricted to NMR on compound in organic solvents, it is not found in
in vivo systems and can therefore never be an internal reference com-
pound. Commonly used internal references are the methyl resonance of
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N-acetyl aspartate for 1H MRS of the brain and the phosphocreatine
resonance for 31P MRS of brain and muscle.
Apart from resonance frequencies and signal amplitudes, additional fea-
tures characterize NMR spectra, of which the splitting of resonance lines
into several smaller lines is the most pronounced. This phenomenon
originates from the fact that nuclei with magnetic moments influence
each other either through space (dipolar coupling) or through chemical
bounds (scalar coupling). In a liquid the dipolar interactions normally
average out to zero due to rapid tumbling, so that no net interaction
between the nuclei remains. However, interactions through chemical
bounds (i.e. interaction of nuclear magnetic moment with the electronic
magnetic moment of the electrons in the bonds) do not average to zero
and give rise to the described features. This interaction is called indi-
rect nuclear spin-spin (or J) coupling because it is mediated by electron
spins. Consider the spin-spin coupling between a proton and a 13C nu-
cleus. For the 1H nucleus, there are in principle two distinct situations,
i.e. the magnetic moment of the scalar coupled 13C nucleus is either
parallel or anti-parallel to the applied main magnetic field. The 1H nu-
cleus senses these different states through the spin of electrons, polarized
by nuclear spin, in the covalent 1H-13C chemical bond. In general, the
spectrum of two coupled spins consists of two doublets, each split by the
same amount, one centered at the chemical shift of the first spin and
one at the shift of the second. The splitting of the doublets is the scalar
coupling, J12, quoted in Hz; the subscripts indicate which spins are in-
volved. The shifts of the two spins are δ1 and δ2, and the corresponding
Larmor frequencies are:
ν0,1 = − 1
2π
γ1(1 + δ1)B0
ν0,2 = − 1
2π
γ2(1 + δ2)B0.
(3.9)
If the two nuclei are of the same type, such a proton, then the two
gyromagnetic ratios are equal and so ν0,1 ≈ ν0,2; such a two spin system
would be described as homonuclear. The opposite case is where the
two nuclei are of different types, such as proton and carbon-13; such
a spin system is described as heteronuclear. There are four possible
combinations of the spin states of two spins and these combinations
correspond to four energy levels. Their energies are given in the table
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3.1. It is easy to see that these energies have the general form:
number spin states M energy
1 αα 1 + 1
2
ν0,1+
1
2
ν0,2+
1
4
J12
2 αβ 0 + 1
2
ν0,1−
1
2
ν0,2−
1
4
J12
3 βα 0 − 1
2
ν0,1+
1
2
ν0,2−
1
4
J12
4 ββ −1 − 1
2
ν0,1−
1
2
ν0,2+
1
4
J12
Table 3.1: Energy levels for the possible combinations of the spin states
of two spins.
Em1m2 = m1ν0,1 +m2ν0,2 +m1m2J12 (3.10)
where m1 and m2 are the angular momentum values along the direction
of the applied magnetic field Iz for spins 1 and 2, respectively. The
selection rule is that ∆M = ±1, with M = m1 + m2. The allowed
transitions and their frequencies are given in the table 3.2 and in Fig.
3.3. In vivo proton MRS spectra hold information on a considerable
transition spin states frequency
1→ 2 αα→ αβ −ν0,2 −
1
2
J12
3→ 4 βα→ ββ −ν0,2 +
1
2
J12
1→ 3 αα→ βα −ν0,1 −
1
2
J12
2→ 4 αβ → ββ −ν0,1 +
1
2
J12
Table 3.2: Complete set of transitions and their frequencies (νij = Ej −
Ei) for a two spin system.
amount of metabolites. Even though the MRS spectrum is extremely
simplified by a detection limit of concentrations above ∼ 1 mM, a typi-
cal in vivo (short TE ) proton MRS spectrum still appears complicated
by the great diversity of atoms weakly and strongly coupled with 1H,
by many overlapping peaks resonating in a small chemical shift range,
by the low spectral resolution of the low field clinical magnets and by
the base noise. This complicates unambiguous peaks assignment and
quantification. Variation of the echo time is one method to further sim-
ply the spectrum at the expense of a reduced signal to noise ratio and
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Figure 3.3: On the left, the energy levels of a two-spin system; the
arrows show the allowed transitions: solid lines for transitions in which
spin 1 flips and dotted for those in which spin 2 flips. On the right,
the corresponding spectrum; it is assumed that the Larmor frequency of
spin 2 is greater in magnitude than that of spin 1 and that the coupling
J12, the splitting of the doublets, is positive but not very great (weakly
coupled spins).
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loss of many metabolite signals. A more time-efficient alternative can
often be provided by spectral editing techniques.
3.2 Diffusion MRI
At microscopic resolutions the water molecules are in constant
random motion. The random motion of the molecules in a liquid or gas
is a phenomenon termed Brownian motion after the Scottish naturalist
who first observed the phenomenon in pollen grains suspended in wa-
ter. Microscopically, these molecules move along arbitrary directions,
but macroscopically they flow from a high to low concentration region.
With Albert Einstein it became clear that Brownian motion is due to
the thermal agitation of the water molecules and that the diffusion is
proportional to the temperature and inversely to viscosity of the solution
and size of the suspended particle:
D =
KT
6πµσ
(3.11)
with K the Boltzmann’s constant, T the absolute temperature, µ the
viscosity of the solution and σ the radius of the particle [51].
While we are familiar with the diffusion of a substance in another host
substance, the physics of diffusion makes no essential distinction be-
tween the two. Hence, the theory of diffusion can be applied to the
diffusion of a substance in its own medium, for example the diffusion
of water in water. This phenomenon is referred to as self-diffusion or,
with some abuse of terminology, simply diffusion.
Supposing an isotropic medium in which molecules flow, from an macro-
scopic observation Adolph Fick deduced his first law that rules the dif-
fusion process [52]:
~J = −D∇C (3.12)
This equation suggests that the flow density ~J (the number of particles
which flow in time and area units) is proportional to the concentration
gradient ∇C of the particles by the diffusion coefficient D (m2/s), sup-
posed constant in the time; the negative sign is to indicate that the
flow is from a high to low concentration region. By using the mass
conservation law
∂C
∂t
+∇ · ~J = 0 (3.13)
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it is possible to obtain the diffusion equation in an isotropic medium
and with time independent diffusion:
∂C
∂t
= D(
∂2C
∂x2
+
∂2C
∂y2
+
∂2C
∂z2
) (3.14)
Furthermore, in Einstein’s relation
λ =
√
2Dt (3.15)
is possible to notice that, in these conditions, the average displacement
λ of the particle is proportional to the square root of diffusion time (free
diffusion regime).
The diffusion is a tridimensional process. The medium structure or the
presence of obstacles, like in biological tissues which have a heteroge-
neous structure, can produce fluxes with different peculiarities along the
various directions; thus, in anisotropic structures is suitable to consider
the diffusion tensor D, a symmetric matrix 3x3:
D =


Dxx Dxy Dxz
Dyx Dyy Dyz
Dzx Dzy Dzz


The geometric representation of this matrix is the diffusion ellipsoid
which symbolizes the tridimensional distance covered from the particle
in diffusion time t. With a coordinate transformation, it is possible to
obtain a diagonal matrix with the D coefficients along the three princi-
pal axes of diffusion (D1, D2, D3).
In heterogeneous materials in which restricting, impermeable, or relax-
ing walls impede the free motion of the particles, like water trapped
in a porous system, there is a restricted diffusion regime where the av-
erage displacement λ of the particle is not more proportional to the
square root of diffusion time and D(t) depends also on time [53]. The
generic diffusion equation, sometimes referred to as Fick’s second law
for diffusion is so:
∂C
∂t
= ∇ · (D∇C). (3.16)
In the common use, two diffusion based techniques are utilized: dif-
fusion weighted imaging (DWI ) is a one-dimensional technique which
measures the projection of all molecular motions along one direction,
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giving the apparent diffusion coefficient (ADC ); diffusion tensor imag-
ing (DTI ) allows to monitor the diffusion process in the tridimensional
space, by measuring DWI in, at least, six directions of the space and
then obtaining the apparent diffusion tensor D. The term apparent is
added because in vivo there are other incoherent motions, like blood
circulation or respiration, which contribute to the signal attenuation to-
gether with molecular diffusion and that MRI techniques are not able
to distinguish them.
The basic idea of magnetic resonance diffusion imaging is to measure
the diffusion of water molecules and use these measurements to probe
the underlying structure of the tissue. Owing to the microscopic length
scale of diffusion in biological tissues, diffusion imaging can reveal his-
tological architecture irresolvable by conventional magnetic resonance
imaging methods. In clinical diagnostics are ever more realized imagines
contrasted in diffusion, by the b-factor, along one direction and paramet-
ric maps where every pixel is proportional to a parameter connected to
tensor D of the corresponding voxel, like the fractional anisotropy (FA)
FA =
√
3[(D1 −D)2 + (D2 −D)2 + (D3 −D)2]√
2(D21 +D
2
2 +D
2
3)
, (3.17)
where D = (D1 + D2 + D3)/3, which measures the eccentricity of the
diffusion ellipsoid and is zero for an isotropic system and 1 for maximum
anisotropy, the mean diffusivity (equal to Tr(D)3 ) which allows to moni-
tor the mean displacement in the t time, and the D coefficient along the
principal axis of higher diffusion to identify oriented structures like mus-
cular fibers or nervous beams (fiber-tract mapping and field mapping, see
Fig. 3.4).
3.3 Used sequences
In this section will be discussed three sequences used in the
experiments, as described in the last chapter.
• The Spin Echo.
Magnetic field inhomogeneities in samples arise from several fac-
tors: imperfections in the uniformity of the imaging magnet, vari-
ations in tissue magnetization, and molecular scale magnetic field
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Figure 3.4: The picture a is an image of an adult brain section, obtained
with MRI techniques and contrasted with T2 parameter; the pictures b
and b) are the corresponding fractional and mean diffusivity maps. The
picture A is the fractional map of another brain section, in this the
strongly anisotropic white matter is discriminated from the isotropic
grey matter; by use a colored codex with red corresponding to right-left
direction, green to down-up and blue to forward-backward, is possible to
characterize the directions of the white matter (B, fiber-tract mapping);
it is possible also to visualize the local orientations by vectors (C, field
mapping).
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variations. The first is, of course, an issue of instrumentation and
is largely a source of artifactual signal intensity-much effort has
been extended to minimizing its impact, both by improving the
magnet technology and by devising data acquisition schemes to
reduce its effects on MR images, thus, variations in main mag-
netic field are no longer a dominant source of transverse decay; 1
or 2 ppm is a typical homogeneity over a 24-cm (head size) volume
in an empty magnet. The second factor is related more strongly
to the tissue sample and is, thus, of more clinical interest. Any
object, when subjected to a magnetic field, will magnetize to a de-
gree slightly more than (paramagnetic) or less than (diamagnetic)
the applied field. The relationship between the field experienced
within a sample and the applied field is known as the magnetic
susceptibility, denoted by χ. Susceptibility is calculated as the ra-
tio of the internal magnetic field to the applied field. Most body
tissues are slightly diamagnetic, thus, at the interface between tis-
sues, a relatively large gradient in the magnet field may exist and,
as a consequence, proton spins in this region will dephase very
rapidly as compared to spins within homogeneous tissue. The
final major factor determining transverse relaxation rates is mag-
netic field variation on the molecular, or atomic, size scale. The
magnetic field experienced by a proton (and thus its resonant fre-
quency) is strongly influenced by the presence of other diamag-
netic or paramagnetic nuclei, such as other protons. Generally, it
is the transverse decay rate from these interactions that yields the
greatest clinical information, as it relates strongly to changes in
intracellular structure chemical environment. However, biological
tissues such as human heads do not necessarily magnetize evenly
and therefore introduce field inhomogeneity to a greater or lesser
degree. All of this would render MRI a relatively limited modal-
ity, but Erwin Hahn discovered in 1950 a trick, the spin echo.
Not taking into account the spin diffusion effects (see the subsec-
tion 3.3.1), this trick effectively eliminates the effects of the local
magnetic field heterogeneities due to the static field and to the
susceptibility mismatch between tissues (γ∆B) dephasing on the
signal intensity.
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Although spin echoes are formed with virtually any combination of
RF pulse amplitudes, they are largest and easiest to understand
as the combination of a 90◦ excitation pulse followed by a 180◦
echo-forming pulse. Imagining the combined signal from a sam-
ple in a spatially inhomogeneous magnetic field, initially, following
a 90◦ excitation pulse, the spins are in-phase and their summed
magnetization results in a macroscopically observable MR signal
(see Fig. 3.5A). Because the spin frequency may differ with lo-
cation (because of magnetic field inhomogeneities) the MR signal
from the summed effects of all spins will decay rapidly (at the rate
T ⋆2 ) as the spins acquire a phase difference. Application of a 180
◦y
RF pulse reverses the relative phases of the spins so that those in
a higher magnetic field have a phase lag compared to those in a
lower field. Because the spin frequency has not changed (it is pri-
marily a function of spin location) the spins come back into phase
and the MR signal is reformed as a spin echo.
Figure 3.6 shows the MR signal as a function of time for spin echo
sequences. As can be seen readily, the spin echo occurs at a time
TE equals to twice the time that elapses between 90◦ and 180◦
pulses.
The most important feature of the spin echo is, therefore, that its
amplitude does not depend directly on the field homogeneity, i.e.,
the echo envelope decay is dominated by T2 relaxation. As TE
is increased, the T2 differences in tissues will become apparent as
the signal from a tissue with a short T2 will be less than that of a
tissue with a long T2.
The imaging spin echo sequence is illustrated in the Figure 3.7.
It is possible to acquire, with one sequence, two echoes at two dif-
ferent TEs adding another 180◦ soft pulse and acquiring also the
relative signal.
• Fast low angle shot (FLASH).
MRI was not, until recently, an effective technique for the study of
dynamic processes, the normal physiological motion from respira-
tion, vascular pulsation, peristalsis, or simply gross subject motion
results in severe degradation of the MR images; artifacts frommov-
ing tissues degrade the signal even from nonmoving tissues. This
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Figure 3.5: Rotating frame depiction of the spin echo. (A) After an
initial excitation pulse, all spins are precessing in phase. (B) Variations
in magnetic field strength, however, cause the angular velocity to differ
with position in the field. With respect to a reference location (o) pre-
cessing at the same rate as the reference frame, some spins may precess
faster (f) or slower (s). With respect to the rotating reference frame
they appear to advance or fall behind spins precessing at the reference
rate. Over time, the difference in frequency causes the phases of the
spins to disperse and the total MR signal from all spins to decay at the
rate T ⋆2 . (C) To form a spin echo, a second RF pulse is applied with a
duration and intensity sufficient to impart a 180◦ spin flip. As a result,
the relative phases of the spins are reversed. (D) With time, the faster
precessing spins catch up, whereas the slower precessing spins fail in
phase. The result is that the signal is reformed as a spin echo.
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Figure 3.6: The MR signal in a spin echo sequence.
Figure 3.7: Imaging SE sequence. The selection gradients are applied
during the 90◦ and 180◦ soft pulses, the phase and frequency encod-
ing gradients between the 90◦ and 180◦ pulses and another frequency
encoding gradient is applied during the signal acquisition to phase the
spins.
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limitation was recognized by MR investigators and many of the
early papers on reductions in imaging time specifically addressed
the use of fast MRI to observe organ function. A general approach
to imaging speed is called low flip angle or FLASH (fast low angle
shot) imaging, which allows the use of shorter TRs by using the
longitudinal magnetization more efficiently.
Decreasing the TR is an obvious means of reducing the overall scan
time, and doing so has a variety of consequences, both positive and
negative. If the excitation pulse is repeated before complete lon-
gitudinal remagnetization (i.e., with a TR short compared to T1
which is relatively long), the strength of the MR signal following
the next pulse will be reduced. Tissues differ greatly in their T1
recovery times and will therefore produce differing signal intensi-
ties: tissues with shorter T1 times will yield signals stronger than
those with long T1’s. This principle, in fact, forms the basis of T1
contrast in MR imaging. The T1 contrast is minimized when TR
is long compared to T1. The T1 contrast is not always desirable;
in particular, it compromises the usable contrast of T2-weighted
images. Beyond the shorter imaging time, and the increase in T1
contrast, decreasing the TR also results in an overall loss in sig-
nal and thus in the signal to noise ratio (SNR). There will also
be a decrease in volume coverage: multislice MR uses the time
available between repetitions on a single slice to collect data from
other slices. As the TR is reduced, the time available for multislice
imaging is also decreased and fewer slices may be collected.
The RF flip angle is defined by the extent to which longitudinal
magnetization becomes rotated into the transverse plane. FLASH
is representative of the gradient echo family of scanning methods,
which use a carefully timed activity in the imaging gradients, in-
stead of a 180◦ pulse, in order to recover the MR signal (see Fig.
3.8). It uses also RF flip angles of less than 90◦ as excitation pulses.
Remembering that the strength of the MR signal is reflected in the
extent of the total magnetization in the transverse planet, as the
RF flip angle α increases, so does the signal strength according to
the simple formula: SI = A sin(α), where A is simply an arbitrary
constant reflecting all other factors. However, with small flip an-
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Figure 3.8: FLASH sequence. This method avoids image artifacts which
may be caused by transverse magnetization remaining at the end of a
TR period of a partial experiment by applying an additional spoiler slice
gradient pulse (SP ) after the detection of a gradient echo (Signal) and
before the application of the radio frequency pulse (RF) of the following
partial experiment.
gles, less time is required for the protons to remagnetize after the
excitation pulse. This allows for adequate longitudinal recovery,
and therefore adequate signal, at shorter TR (see Fig. 3.9 and
3.10). Differences in longitudinal recovery between tissues repre-
sent a T1 contrast. As a consequence, in FLASH imaging, shorter
TRs may be used to achieve images without a T1 contrast. In
the very short TR regime, with TR less than one-tenth of T1, a
20◦ flip angle yields several times the signal intensity of a 90◦ flip
angle. It is also to note, on the other hand, that the maximum
signal strengths can be achieved only with a 90◦ flip angle and at
long TR. The effect of TE is here to control the T ⋆2 contrast.
The advantages of shallow flip angle excitation cannot be realized
when 180◦ RF pulses are used to form spin echoes. The FLASH
method works, in part, because the longitudinal magnetization is
relatively undisturbed by a shallow excitation pulse. In contrast,
one effect of a 180◦ pulse is to invert the longitudinal magnetiza-
tion. So, the use of a shallow excitation flip angle in combination
with 180◦ pulses actually prolongs the time required for signal re-
covery because the longitudinal magnetization must now recover,
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Figure 3.9: When small flip angles are used for excitation, there is rel-
atively little loss of longitudinal magnetization (shown vertically) and
only this small amount must be recovered during the TR period, as a
result the tissue remagnetize more rapidly.
Figure 3.10: For long repetition times, larger flip angles produce a
greater signal. As the TR is decreased, however, the shallow flip angles
yield more signal. This is because, at shorter TRs, the magnetization
does not have the time to recover fully between repeated RF excitation
pulses.
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not from zero, but from a negative initial value. Omitting the 180◦
pulse, the MR signal decays at the rate T ⋆2 .
FLASH, as most of the popular MR imaging strategies, requires
repeated excitations, any excitation in fact allows to acquire a
line of the k space; in this technique, steps are taken to destroy
any residual transverse magnetization prior to each excitatory RF
pulse. In this way, only longitudinal magnetization is incorporated
into the steady state. In FLASH, after the signal is collected in the
form of a gradient echo, a gradient pulse called spoiler is used to
destroy any remaining transverse magnetization. From there, the
magnetization recovers longitudinally at the tissue T1 rate and the
degree of recovery is the same with each cycle and thus reaches a
steady state. The short TR in FLASH necessitates the use of a
spoiler; without it, some transverse magnetization would remain
at the beginning of the next RF pulse.
• Diffusion weighted Segmented Echo-Planar Imaging (EPI).
An altogether different approach to scan time reduction is afforded
by echo-planar imaging (EPI) as put forward by Mansfield (1977).
In EPI all of the spatial encoding is performed following a single ex-
citation pulse (i.e., the TR is infinite, see Fig. 3.11). To do so, the
Figure 3.11: EPI sequence.
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gradient amplitude is increased up to its maximum practical limit
to minimize the time required to detect the position-dependent
frequency differences. Brief pulses of the phase-encoding gradient
are made during the readout period to encode the signal. As sug-
gested earlier, this requires rather large gradient amplitudes and
rapid gradient switching to yield adequate resolution (gradient-
time product) in the brief period that the MR signal is available.
Rapid switching of the gradient field results in a time-varying mag-
netic field of significant magnitude. Because the human body is a
fair conductor, this varying magnetic field can cause current flows
in the body, resulting ultimately in neural stimulation (Reilly,
1989; Cohen et al., 1990; Budinger et al., 1991). It is possible to
build safe whole body gradient sets with amplitudes to 2.5 G/cm
and 0.5 msec switching times and head gradients to about 5 G/cm
with 0.25 msec switching times. Therefore, complete MR images
may be acquired in as little as 20 msec with EPI, with spatial res-
olution on the order of 1 mm. Compared to FLASH-style imaging,
EPI has much more flexible contrast, as its imaging speed depends
on modifications to the spatial-encoding procedure, not to the RF
pulse sequence that determines the signal behavior. In practice,
this means that it is practical with EPI to obtain images with ei-
ther RF spin echoes, or with gradient echoes, so that the degree of
T2 and T
⋆
2 weighting may be varied freely and somewhat indepen-
dently. It is also an order of magnitude or so faster and recovers
the MR signal more efficiently than FLASH scanning.
One of the largest problems in using echo planar imaging is the
level of image distortion due to susceptibility, that is observed.
This can make some structures hard to detect using EPI. In or-
der to improve the quality images, an approach that can be taken
is to use a technique which is a hybrid of EPI and 2DFT, called
interleaved or segmented EPI. This technique acquires the image
in two or more FIDs, thereby trading some of the speed of EPI to
gain some of the image quality of 2DFT. Interleaved EPI was pro-
posed by McKinnon, as a way of implementing EPI on a standard
clinical scanner, which did not have the necessary fast ramping
gradients. It also has benefits however for scanners which can
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carry out conventional EPI, ranging from reducing distortion, im-
proving linewidth, to increasing signal to noise.
Interleaved EPI acquires all the data points required to make up
the image in several FIDs. The easiest way to picture how this is
done is to look at the k-space coverage diagram (see Fig. 3.12)
for a two shot interleaved EPI sequence (see Fig. 3.13). The
first interleave covers the whole of k-space in alternate lines, and
then the second pass fills in the lines between. The same prin-
ciple holds for any number of interleaves, up until the technique
essentially becomes a 2DFT experiment. The technique is some-
Figure 3.12: k-space coverage diagram for a two shot interleaved EPI
sequence.
times referred to as segmented EPI, since k-space is covered in
two or more segments. It seems appropriate to refer to the kind
of technique shown in Figure 3.12 as interleaved EPI, since the
two shots are indeed interleaved on reconstruction, and to refer
to other multi-shot techniques as segmented EPI. The parameter
EPI Factor is used to specify the number of k-space profiles col-
lected per excitation.
In order to measure the rate of molecular flow, some kind of phase
encoding that is flow sensitive can be applied. This is done by ap-
plying a magnetic field gradient along the direction in which flow
is to be measured. A large gradient dephases the spins depending
on their position along the gradient. This gradient is then re-
versed, which will completely rephase any stationary spins. Spins
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Figure 3.13: Pulse sequence diagram for a two shot interleaved EPI
experiment.
that have moved however will not be completely rephased because
such movement alters the magnetic field experienced by the spins
so that the phase acquired during the refocusing gradient is not
exactly opposite to that acquired during the defocusing gradient.
(see Fig. 3.14). If the flow is coherent within a voxel, when the
spins are imaged the phase difference can be calculated, and by
varying the time between the forward and reverse gradients the
flow can be calculated. Diffusion is measured in a similar way,
but as diffusion is a random process we expect to see a smooth
attenuation of the intensity of the refocused signal as the diffusion
contribution increases, following the equation:
S = S0e
−bADC , (3.18)
where S0 is the signal intensity in the absence of a gradient, ADC
is the apparent diffusion coefficient averaged on TE time, which
generally decreases as the molecular mass increases, and the b −
factor is the parameter by which the images are contrasted in
diffusion; relaxation has been ignored. Following the equation:
b = γ2g2δ2(∆ − δ/3), (3.19)
the b−factor depends on the time between the two gradient pulses
(∆), on the duration (δ) and strength (g) of the gradient pulses
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Figure 3.14: Flow encoded imaging. (a) Spins are dephased with a
gradient in the x direction. (b) After a time δ the gradient is applied in
the opposite direction. (c) Spins that are stationary will be completely
rephased, whereas spins that have moved along x in the time δ will be
left with a residual phase shift.
and on the nuclear gyromagnetic factor of interest (γ). Indeed,
for a given pair of gradient pulses spins diffuse during the delay
between the two pulses which determines the attenuation of the
echo. Moreover, the stronger the gradient the more rapidly the
phase varies across the sample and thus the more rapidly the echo
will be attenuated.
3.3.1 The internal gradient (Gi)
In spongy bone, the susceptibility mismatch between the solid
matrix and interstitial liquid bone marrow (∆χ = χmarrow − χbone ≃
3 ∗ 10−6 ≫ |∆χ|brain) [54] generates internal gradients with magnitude
depending on the geometry and orientation of the trabeculae with re-
spect to the static magnetic field direction and scales with the magnetic
field strength. The interface separating two materials of different mag-
netic susceptibility gives rise to an induced local magnetic field Bind
which produces heterogeneities in the static magnetic field B0 generat-
ing the so called internal gradient Gi. For surfaces with complex geome-
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tries the calculation of Bind is difficult but it is possible to demonstrate
the following relation [54]:
Bind ∝ ∆χB0Acos(α), (3.20)
where ∆χ is the susceptibility difference between the two materials, A
the surface separating the materials and α the angle between the static
field and a vector at a 90◦ angle to the surface. The signal loss given at
a TE for a gradient echo experiment can be described by:
S(TE) ∝ S(0)exp
(
−TE
T ⋆2
)
, (3.21)
with T ⋆2 (see eqn. 3.22) depending on the local magnetic field het-
erogeneities γ∆B (due to the static field and Gi) and on T2 spin-spin
relaxation time or true T2 (linked to the intrinsic coherence loss of the
spin system):
1
T ⋆2
=
1
T2
+ γ∆B. (3.22)
The use of GE-type sequence ensures the so called static dephasing
regime, that is when the NMR signal decay due to the magnetic mo-
ment dephasing resulting from the local differences in the nuclear fre-
quencies occurs faster than the diffusion phenomena and which implies
that diffusion effects are negligible [55]. Vice-versa by using SE-type
sequence [56] the diffusion of bone marrow molecules in the local mag-
netic field gradient becomes an important factor; molecules interchange
their positions resulting in a small phase difference between their nuclear
magnetic moments and this generates an irreversible signal loss [57]. In
this case of signal loss, as function of the TE in a SE experiment:
S(TE) ∝ exp(−TE
T2
) = exp
[
−
(
TE
T true2
)
− 1
12
(γGi ∗ TE)2ADC ∗ TE
]
,
(3.23)
where ADC is the apparent diffusion coefficient and:
1
T2
=
1
T true2
+
1
12
(γGi ∗ TE)2ADC. (3.24)
Thus, in SE measurements the additional decay of the echo amplitude
is due to diffusion of fluid molecules in the local magnetic field gradient
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Gi. As a consequence, bone marrow T2 and T
⋆
2 relaxation times are di-
rectly related to the density of the surrounding solid-state network and
its spatial geometry. The resulting more rapid loss of coherence becomes
greater as long as the concentration of solid network in the surrounding
homogeneous liquid spin system increases. On the contrary the increase
in trabecular spacing reduces the spatial field inhomogeneity and thus
prolongs the spin-spin relaxation due to the additional decay of the echo
amplitude and T ⋆2 . This behavior is substantial for T
⋆
2 and reduced for
T2. In systems like spongy bone, it is possible to quantify mean Gi from
the attenuation of the SE signal as a function of different TE s. Further-
more, a measure of the apparent diffusion coefficient (ADC) and/or a
measure of T true2 are needed to reduce the number of unknown parame-
ters and improve the fit quality. In all in vitro and in vivo experiments
reported in this work, the ADC was measured and inserted in equation
3.24 to extract Gi and T
true
2 using a fitting procedure.

Experimental results and
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Chapter 4
1H NMR Spectroscopy of
bone marrow
4.1 State of the art
Lipids are increasingly believed to play an important role in the
pathogenesis of osteoporosis [58] and other conditions, such as hyperten-
sion and coronary artery disease [59,60]. Epidemiologically, osteoporotic
postmenopausal women are at significantly greater risk for cardiovascu-
lar disease than age-matched controls [61], with higher serum lipid lev-
els having been identified in both diseases [62]. In adult bone marrow,
adipocytes are the most abundant stromal cell phenotype and are be-
lieved to influence both hematopoiesis and osteogenesis [63]. Adipocytes
and osteoblasts share a common progenitor (mesenchymal stem cells) in
the bone marrow, such that increased adipogenesis may be associated
with decreased osteoblastogenesis. Accumulating evidence suggests that
a reciprocal relationship may exist between these two processes [64].
However, the molecular mechanism underlying this reciprocal relation-
ship is not yet fully understood.
Under high-resolution analytical conditions, signals from pro-
tons adjacent to double bonds are easily resolved, and it is a relatively
simple matter to assess fat composition by 1H NMR spectroscopy. At
7 T, for example, 10 resonances can be resolved (see Table 4.1). Six
resonances contribute equivalent information about triglyceride compo-
sition (see Fig. 4.1): the CH3 methyl protons (at ∼0.90 ppm), the
CH2 methylene protons α- (at ∼2.25 ppm) and β- (at ∼1.59 ppm) to
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the carbonyl, and the glycerol backbone CH and CH2 protons. Hence,
there are only four additional informative resonances to consider: 1)
bulk CH2 methylene protons (at ∼1.3 ppm); 2) allylic CH2 protons, α-
to a double bond, at 2.03 ppm; 3) diallylic (also called bis-allylic) CH2
protons at 2.77 ppm; and 4) olefinic, double bond −CH=CH− protons
at 5.31 ppm. Extension of this analysis method to low magnetic fields
Signal Chemical
shift (ppm)
Functional group
1 0.82-0.94 −CH3 (terminal methyl protons (saturated, oleic and linoleic))
2 0.94-1.03 −CH3 (terminal methyl protons (linolenic))
3 1.20-1.43 −(CH2)n− (methylene protons (saturated))
4 1.55-1.69 −OCO−CH2−CH2− (β-methylene protons (carbonyl))
5 1.93-2.13 −CH2−CH=CH− (allyl methylene protons)
6 2.25-2.36 −OCO−CH2− (α-methylene protons)
7 2.73-2.87 =HC−CH2−CH= (divinyl methylene protons)
8 4.10-4.35 −CH2OCOR (methylene protons (glyceryl))
9 5.23-5.29 CHOCOR (proton on carbon atom 2 of glyceryl group)
10 5.29-5.43 −CH=CH− (olefinic protons)
Table 4.1: 1H NMR spectral peaks assignment of bone marrow fat:
chemical shift ranges and functional groups [65–67].
gives rise to the overlapping lipid peaks, due to the worst chemical shift
resolution.
At 1.5 or 3 T, only four resonances can be resolved by the ap-
plication of prior knowledge (labeled 1, 3, 5, 10 in Table 4.1, see Fig.
4.2). Water (4.65 ppm) and lipid (1.3 ppm) peak amplitudes can be
measured to determine marrow fat content Mfc, which is defined as
the relative fat signal amplitude in terms of a percentage of total sig-
nal amplitude (water and fat) and calculated according to the following
equation:
Mfc =
Ifat
Ifat + Iwat
· 100 (4.1)
where Ifat and Iwat are the peak amplitudes of fat and water, respec-
tively. Many 1H MR spectroscopic studies focused to measure the Mfc
of the lumbar spine and to its correlation with bone mineral density
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Figure 4.1: Chemical structure of a triglyceride with three different fatty
acids.
and age of the subjects: a mild significant negative correlation or no
correlation was observed between T -score or BMD and vertebral Mfc
[68–72] and a significant positive correlation between age and vertebral
Mfc [72,73]. Moreover, Yeung et al and Griffith et al obtained a signif-
icantly higher vertebral marrow fat content for the osteoporotic group
than for the normal bone density group [68, 71], whereas Schellinger et
al observed that in an abnormal group, which consisted of subjects with
MR imaging evidence of vertebral bone weakness, the Mfc was higher
than that in a control subject group, for the same age decade [70,73].
The relation between Mfc and vertebral bone weakness could be ex-
plained by three considerations [73]. First, trabecular rarefication with
thinning, which is commonly reported as the main cause of bone weak-
ness in osteoporosis, results in open spaces among the trabecular mesh
and some have suggested that there is compensatory filling of these
spaces with fatty marrow [74–81]. Therefore, increased vertebral fat
content could mirror bone loss. Second, marrow composition may af-
fect elasticity of the bone superstructure [82]; red marrow is said to
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Figure 4.2: 1H-MRS performed on the L3 vertebral body of a 72-
year-old woman with osteoporosis (T -score = 2.8) and a 40-year-old
premenopausal woman. A: Spectrum (bottom trace) acquired from a
woman with osteoporosis shows a relatively intense lipid peak from bulk
methylene protons compared to the water peak (4.65 ppm), indicating
increased marrow fat content. The middle trace shows the fitted spec-
trum using prior knowledge, and the top trace is the residual spectrum.
B: Spectrum acquired from a premenopausal woman shows a relatively
intense water peak compared to bulk methylene protons [68].
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contribute to hydrostatic strengthening, whereas fatty marrow is asso-
ciated with greater compressibility of vertebrae. Fatty marrow would
cause hydrostatic weakening of a vertebra. Third, bone marrow relates
to the regulation of bone turnover. Nuttal et al [83] have reported
that bone-marrow stromal cells can undergo adipogenesis or osteoblas-
togenesis. There is a reciprocal relationship between adipocytes and
osteoblast phenotypes; excessive expression of one versus the other may
have significance in the context of osteoporosis. Thus, a decrease in os-
teoblastogenesis in bone marrow may result in increased adipogenesis.
Predominance of fatty marrow therefore could be a result of increased
adipogenesis and have a negative effect on osteogenesis. They there-
fore recognized a therapeutic opportunity for treatment of bone loss by
pharmacologic inhibition of bone marrow fat.
The purpose of our study was to investigate the marrow fat
content and its correlation with T -score parameter and age of the sub-
jects, in an anatomical region rich of yellow marrow, such as the calca-
neus.
4.2 Materials and methods
Twelve postmenopausal healthy females (mean age 59±5 years
and mean T -score−1.20±0.52), thirty-seven postmenopausal osteopenic
females (mean age 62 ± 7 years and mean T -score −2.66 ± 0.39) and
twenty-eight postmenopausal osteoporotic females (mean age 66 ± 6
years and mean T -score −3.92 ± 0.49), participated to this study. The
inclusion criteria were 1) any preexisting bone disease (such as tumor,
metastases, or metabolic disorder), 2) absence of documented calcaneal
abnormality, 3) absence of drug therapy known to affect bone density,
and 4) absence of implants contraindicated for MR examination. Six
premenopausal females (mean age 29 ± 3 years) were also recruited as
young control subjects. The ethics committee of our institution (Santa
Lucia Foundation) approved the study and written consent was obtained
from all subjects prior to examination. The normal, osteopenic or osteo-
porotic status of each postmenopausal subject was assessed with QCT
lumbar vertebral BMD measurements according to the criteria described
in section 2.3 (normal with T -score ≥ −1.8, osteopenia with −3.3 < T -
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score < −1.8, osteoporosis with T -score ≤ −3.3).
The images were obtained by using a circular polarized vol-
ume head-coil for radiofrequency (RF) transmission and reception, on
a Siemens Allegra MR-scanner operating at 3.0 T (Siemens Medical
System, Erlangen, Germany). Control imaging experiments were per-
formed on a phantom constituted by water (1 l), salt (5 g), Agar (15 g),
Cr (7.06 g) and Lac (3.6 g) to check the RF head coils. Each volunteer
was placed in the supine position with the right foot placed in the RF
coil, as shown from the axial localizer image reported in Fig. 4.3.
Single voxel spectroscopy with TE=22 ms, TR=5 s, NS=32
Figure 4.3: Axial localizer of the right foot with the white line indicating
location of oblique sagittal FLASH and MCSE images in the calcaneus.
See the next chapters.
was used to obtain bone marrow proton spectra. The voxel size of
15x15x15 mm was positioned at the center of the calcaneus. All spectra
were analyzed by LCModel method. The LCModel method analyzes
an in vivo spectrum as a Linear Combination of Model in vitro spec-
tra from individual metabolite solutions, like for the analysis of the
brain metabolites, or it simulates the metabolites of interest, like for
the analysis of lipid spectra (our case) [84]. A nearly model-free con-
strained regularization method automatically accounts for the baseline
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and lineshape in vivo without imposing a restrictive parameterized form
on them. LCModel is automatic (non-interactive) with no subjective
input. Approximately maximum-likelihood estimates of the metabo-
lite absolute concentrations and their uncertainties (Crame´r-Rao lower
bounds) are obtained.
As is possible to observe in Fig. 4.4, the spectra from yellow bone mar-
row of calcaneus, but also of femur and other locations in the limbs
of adults, are dominated from signals of fatty acids (for hematopoietic
marrow like in the pelvis and in the spine, instead, considerable water
signals occur in the spectra, see Fig. 4.2) because this type of mar-
row contains fat cells filled with triglycerides mainly. For lipid spectra,
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Figure 4.4: Localized spectrum in the bone marrow of the calcaneus
of a 66-years-old women with T -score -2.5, acquired at 3.0 T and an-
alyzed by LCModel method. The metabolite absolute concentrations,
their uncertainties and their ratios with water absolute concentration
are reported for every metabolite on the right side. The residuals (cal-
culated from the data values minus the fit values), are plotted at the
top of the plot.
LCModel measures the concentrations of the four lipid peaks (Lip09,
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Lip13, Lip20 and Lip53 at about 0.9, 1.3, 2.0 and 5.3 ppm and labeled
1, 3, 5, 10 respectively in Table 4.1) and of the water peak (at about 4.65
ppm) as resonance areas of the metabolite (the term ”resonance area”
is used instead of ”peak area”, since LCModel attempts to resolve over-
lapping signals, even when they form only one combined peak). The
calcaneal marrow fat content Mfc, defined as the relative fat signal
amplitude in percentage of total signal amplitude (water and fat), was
calculated for all subjects, according to the equation 4.1 where Iwat is
the water peak concentration and Ifat is the concentration sum of the
Lip09, Lip13 and Lip20 peaks, as calculated by LCModel, because Lip09
is difficult to resolve from Lip13 and Lip20, therefore the concentration
sums Lip09+Lip13+Lip20 is more accurate. Mfc values were averaged
across all subjects for each bone density group (normal, osteopenia and
osteoporosis, labeled 1, 2 and 3 respectively) and for the control group
(labeled C ) and their standard deviations were calculated.
The mean values of T -score, Age andMfc variables were com-
pared among the three bone density groups and between the control
and normal group with the one-way analysis of variance test (one-way
ANOVA). Pearson correlation coefficients (r) were calculated to assess
the linear relationship between pairs of variables for all postmenopausal
subjects and for all subjects of each bone density group. A p value of less
than 0.05 was considered to indicate a statistically significant difference.
4.3 Results and discussion
The results reported in Tab. 4.2 and in the graphs in Fig. 4.5
show that our three bone density groups are significantly well separated
in T -score values and their mean Age values have an increasing trend
as bone density decreases. Age differences are statistically significant
between osteopenia and osteoporosis groups only (p < 0.01), therefore
we can rule out age differences as a possible confounding factor in this
study for the normal-osteopenia comparisons. Conversely, mean Mfc
values don’t point out any statistically significant difference with bone
density changes, neither between the control and normal group.
For paired data of all postmenopausal subjects, we obtained
a low significant negative correlation between T -score and Age (r =
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Figure 4.5: Graphs show calcaneal marrow fat content, Age and T -score
for three bone density groups (normal bone density, osteopenia, and
osteoporosis). Mean Age values are characterized by an increasing trend
and mean T -score values are characterized by a decreasing trend as bone
density decreases, while mean Mfc values have no trend. Horizontal
bar = mean value for each group (see Tab. 4.2). (Normal: -blue,
osteopenia: -green, osteoporosis: N-red).
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Figure 4.6: T -score, Age and Mfc paired values of all postmenopausal
subjects are plotted and examined by linear correlation with their coef-
ficients of determination (R2).
Parameter T-score Age Mfc
T-score 1 −0.425 ∗ ∗(2) 0.080
Age 1 0.102
Mfc 1
Table 4.3: Pearson correlation coefficient test results (r) between pairs
of variables (among T -score, Age and Mfc variables) for all post-
menopausal subjects. Notes: 1. Data are Pearson correlation coeffi-
cients (r); 2. ∗ (p < 0.05); ∗∗ (p < 0.01); 3. (1) little (0≤ r ≤0.29),
(2) low (0.3≤ r ≤0.49), (3) moderate (0.5≤ r ≤0.69), (4) high (0.7≤ r
≤0.89), (5) very high (0.9≤ r ≤1).
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−0.425, p < 0.01), but no significant correlation between T -score and
Mfc and between Age and Mfc (see Tab. 4.3 and Fig. 4.6). Any
significant correlation in each bone density group was also observed for
paired data of the three variables.
Our results partly agree with literature findings, for the ab-
sence of correlation between T -score and Mfc, but partly disagree for
the absence of statistically significant correlation between Age andMfc,
and for the absence of any statistically significant trend of mean Mfc
values with bone density changes. These disagreements can be ascribed
to the different anatomical region chosen, and in particularly to the dif-
ferent kind of bone marrow investigated.
As previous described, in calcaneus a predominance of fatty marrow
(Mfc ranges from about 83% to 98% [72]) exists, whereas in vertebra
there is a predominance of hematopoietic marrow rich of water (Mfc
ranges from about 27% to 70% [72]). In our results, Mfc ranges from
about 80% to 94%, in good agreement with Liney et al results [72]; this
small range hampers to obtain a linear correlation between Age and
Mfc [72] and to point out the probable skill of Mfc to detect bone
density changes. Moreover, in this situation it’s very hard to discrim-
inate the little compensatory filling, as suggested before, of the inter-
trabecular spaces created by osteoporosis with fatty marrow, from the
high marrow fat content of calcaneus. However, the Mfc information
obtained, will be need for the analysis in the next chapters.
Chapter 5
Bone marrow diffusion
5.1 State of the art
As previous underlined, osteoporosis is a disease that predis-
poses to bone fracture and it is clinically diagnosed by means of bone
mineral density (BMD).
The poor correlation between fracture prevalence and BMD diagnosis
suggests that other factors besides low BMD contribute to bone fragility;
in effect, with osteoporosis, in addition to low BMD, the bone micro-
architecture is rearranged or disrupted, the amount and the variety of
proteins in bone is altered and the bone marrow quality also is altered.
Many factors associated with increased individual susceptibility to os-
teoporosis have been identified, but the actual pathophysiology of os-
teoporosis, however, remains unclear.
The MR imaging techniques developed for better understand-
ing of osteoporosis are MR relaxometry and high-resolution MR imag-
ing; these are based on the study of trabecular bone. Although MR
imaging techniques employ no radiation compared to DXA and QCT,
one feature common all these techniques is the focus on measuring the
structural end-point of bone loss. They provide no information on the
physiological or functional changes associated with osteoporosis. Other
MR imaging techniques can enable investigation of two aspects of bone
physiology that may provide insight to the pathogenesis of osteoporosis:
marrow fat content and marrow diffusion.
Apparent diffusion coefficients derived from MR diffusion imaging has
been used successfully in differentiating between benign and malignant
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acute vertebral body compression fractures [85, 86]. Based on the al-
tered cellular composition of the bone marrow induced by malignant
cell proliferation, measurable changes in the random motion of water
molecules within bone tissues can be detected. Evidence obtained from
an in vivo MR spectroscopy study has shown that changes in the pro-
portion of bone marrow fat may be associated with bone weakening [73].
However, it is unclear whether changes in the bone marrow composition
associated with osteoporosis and their effect on marrow water diffusion
may also be detected by means of MR diffusion imaging; moreover, the
relationship between ADC in vivo and T -score is not clear.
Many MR studies focused to measure the ADC of the lum-
bar spine and to its correlation with bone mineral density and with
Mfc: Yeung et al [87] demonstrated vertebral diffusion restriction in
patients with osteoporosis, but their study was limited secondary to
the small number of subjects; Griffith et al [71, 88] found a decreas-
ing vertebral ADC for decreasing BMD, without statistically significant
differences among the osteoporotic, osteopenic and normal bone atten-
uation groups, no correlation between ADC and T -score and a mild
positive correlation between ADC and vertebral marrow fat content;
Hatipoglu et al [89] found a decreasing vertebral ADC for decreasing
BMD with statistically significant differences only between normal and
osteopenic groups and a mild positive correlation between ADC and
T -score; Ueda et al [90] obtained a strong negative correlation between
ADC and T -score and a strong positive correlation between ADC and
Mfc, at low-intermediate marrow fat content (20%-60%).
This lack of clear findings in literature, mostly for the situation with
very high marrow fat content, induced us to investigate the ADC pa-
rameter and its correlation with T -score, Mfc and Age of the subjects,
in calcaneus, in talus and in some their different regions.
5.2 Materials and methods
For each volunteer (see section 4.2), we acquired sagittal view
images obtained on the same slices (5 mm thickness) and by using
the same foot position. We performed a high resolution FLASH im-
age at 3.0 T using square FOV=180 mm, matrix=512x512, TE=10
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ms, TR=600 ms, BW=160 Hz/pixel and a sagittal diffusion weigh-
ted segmented Echo-Planar Imaging (EPI) with TE=86 ms, TR=1.5
s, BW=1954 Hz/pixel, square FOV=192 mm, matrix=128x128, reso-
lution=1.5x1.5x10 mm, epi factor=7, diffusion mode= phase (anterior-
posterior direction) and b-value=0, 8000, of the heel of every volunteer.
N data subjects were not analyzed due to motion artifacts on DWI im-
ages. As a consequence, five premenopausal females (mean age 29 ± 3
years), eight postmenopausal healthy females (mean age 58 ± 4 years
and mean T -score −1.34±0.44), twenty-five postmenopausal osteopenic
females (mean age 61 ± 7 years and mean T -score −2.62 ± 0.41) and
twenty-two postmenopausal osteoporotic females (mean age 66±6 years
and mean T -score −3.91 ± 0.45).
With the same images, it was possible to analyze the whole
calcaneus (labeled CALCA) and the whole talus (labeled AT ) (see Fig.
5.1). We also focused our attention on a talar region (labeled AC ) close
to calcaneus and on three different calcaneal sites: the subtalar (labeled
ST ), the tuber calcanei (labeled TC ) and cavum calcanei (labeled CC )
regions. The ST region is characterized by the highest trabecular den-
sity because it transmits the stresses exerted by the weight of the body
from the tibia, via the talus to the heel, then the trabecular density
progressively decreases in TC and in CC regions. The CC region is
characterized by the lowest and isotropic trabecular density [91,92].
Apparent diffusion coefficients ADC were obtained from dif-
fusion weighted segmented EPI images, substituting in the equation
3.18 the b-values and the respective mean signal intensities of the whole
calcaneus, the whole talus and of the AC, ST, TC and CC regions,
of every subjects. ADC values of each region, were averaged across
all subjects for each bone density group (normal, osteopenia and os-
teoporosis, labeled 1, 2 and 3 respectively) and for the control group
(labeled C ) and their standard deviations were calculated. ADC values
from postmenopausal women were also graphed, for each region, with
their averages and were plotted versus marrow fat content Mfc values
obtained in the previous chapter (see section 4.3). For each region, the
mean ADC values were compared among the three bone density groups
and between the control and normal group with the one-way analysis
of variance test (one-way ANOVA) and Pearson correlation coefficients
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(r) were calculated to assess the linear relationship between pairs of
variables (among T -score, Age, Mfc and ADC variables) for all post-
menopausal subjects and for all subjects of each bone density group.
A p value of less than 0.05 was considered to indicate a statistically
significant difference.
5.3 Results and discussion
The trabecular bone structure in the calcaneus is clearly de-
picted in the high resolution MR image reported in Fig. 5.1. Here, the
trabecular bone network appears dark while the bone marrow appears
bright. The regional heterogeneity in the trabecular architecture and
the trabecular bone density are also apparent from the image. The tra-
becular structure appears more oriented and denser in the ST region
and sparser with no preferred trabecular platelets orientation in CC re-
gion. In Fig. 5.2 we have reported sagittal diffusion weighted images
of the heel (the first in literature) in a normal (A), osteopenic (B) and
osteoporotic (C) postmenopausal female subject.
The results reported in Tab. 5.1 and in the graphs in Fig.
5.3 show that the mean ADC values of the three bone density groups
are characterized by an increasing trend as bone density decreases but
these differences are statistically significant between the three groups in
subtalar region only. ST region is the only one with statistically sig-
nificant discrimination between normal and osteopenic group by ADC
values, and CC is the best region to discriminate between osteopenic
and osteoporotic group. Conversely, ADC values don’t point out any
statistically significant difference between the control and normal group,
in each analyzed region. The mean ADC values obtained in this work
are one order of magnitude lower than those reported in previous stud-
ies focused on vertebrae [87, 89, 90, 93]; this difference is due to higher
marrow fat content in calcaneus compared to those in vertebrae, which
restricts water molecular diffusion.
For paired data of all postmenopausal subjects, we obtained
a moderate significant negative correlation between T -score and ADC
in CC region (r = −0.497, p < 0.01) and a low significant negative cor-
relation in all the other analyzed regions (see Tab. 5.2). Even if ADC
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ST
TC
CC
CALCA
AT
AC
Figure 5.1: Sagittal high resolution MR image of the heel showing the
investigated locations: the whole calcaneus (labeled CALCA), the whole
talus (labeled AT ), the talar region (labeled AC ) close to calcaneus and
the three different calcaneal sites with their large regional variation in
trabecular bone density and orientation, the subtalar (labeled ST ), the
tuber calcanei (labeled TC ) and cavum calcanei regions (labeled CC ).
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A1 A2
B1 B2
C2C1
Figure 5.2: Sagittal diffusion weighted segmented Echo-Planar Imaging
(EPI) of the calcaneus and talus in a 55-years-old normal female vol-
unteer (A1 with b=0, A2 with b=8000), in a 69-years-old osteopenic
female volunteer (B1 with b=0, B2 with b=8000) and in a 64-years-old
osteoporotic female volunteer (C1 with b=0, C2 with b=8000) at 3.0 T.
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Figure 5.3: Graphs show ADC values, for three bone density groups
(normal bone density, osteopenia, and osteoporosis), in the whole calca-
neus (CALCA), the whole talus (AT ) and in the ST, AC, TC and CC
regions. Mean ADC values increase as bone density decreases; ST re-
gion is the only one with statistically significant discrimination between
normal and osteopenic group, CC is the best region to discriminate be-
tween osteopenic and osteoporotic group. Horizontal bar = mean value
for each group (see Tab. 5.1). (Normal: -blue, osteopenia: -green,
osteoporosis: N-red).
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Parameter T-score Age Mfc AC-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.316∗(2)
Age 1 0.102 0.155
Mfc 1 −0.148
AC-ADC 1
Parameter T-score Age Mfc AT-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.376 ∗ ∗(2)
Age 1 0.102 0.214
Mfc 1 −0.163
AT-ADC 1
Parameter T-score Age Mfc CALCA-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.463 ∗ ∗(2)
Age 1 0.102 0.108
Mfc 1 −0.301∗(2)
CALCA-ADC 1
Parameter T-score Age Mfc ST-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.488 ∗ ∗(2)
Age 1 0.102 0.135
Mfc 1 −0.250
ST-ADC 1
Parameter T-score Age Mfc TC-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.350 ∗ ∗(2)
Age 1 0.102 0.100
Mfc 1 −0.143
TC-ADC 1
Parameter T-score Age Mfc CC-ADC
T-score 1 −0.425 ∗ ∗(2) 0.080 −0.497 ∗ ∗(3)
Age 1 0.102 0.177
Mfc 1 −0.248
CC-ADC 1
Table 5.2: Pearson correlation coefficient test results (r) between pairs
of variables (among T -score, Age, Mfc and ADC variables, in each
investigated region) for all postmenopausal subjects. Notes: 1. Data
are Pearson correlation coefficients (r); 2. ∗ (p < 0.05); ∗∗ (p < 0.01);
3. (1) little (0≤ r ≤0.29), (2) low (0.3≤ r ≤0.49), (3) moderate (0.5≤
r ≤0.69), (4) high (0.7≤ r ≤0.89), (5) very high (0.9≤ r ≤1).
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parameter is able to distinguish the three bone density groups, accord-
ing to WHO criteria, it has a low or moderate significant correlation
with T -score values and this demonstrates that it doesn’t depend only
on the bone density but also on other factors bound to the bone quality,
as previous underlined. No significant correlation between ADC and
Age and almost never between ADC and Mfc was observed. A low
significant negative correlation between Mfc and ADC was obtained in
the whole calcaneus for all the postmenopausal subjects (r = −0.301, p
< 0.05) and for the osteoporotic subjects (r = −0.429, p < 0.05).
Our results agree with Ueda et al [90] findings at low or inter-
mediate marrow fat content (20%-60%), for the statistically significant
negative correlation between ADC and T -score values, but disagree with
Griffith et al [71, 88] and Hatipoglu et al [89] findings at intermediate-
high marrow fat content (45%-80%), for the opposite trend of mean
ADC values obtained with bone density changes. These different trends
can be ascribed to the different marrow fat contents analyzed.
Under low or intermediate marrow fat content, water molecules seem re-
stricted by the trabecular bone rather than fat cells, thus the change in
ADC value depends on the trabecular bone architecture under thisMfc
condition. Conversely, under intermediate or high marrow fat content,
water molecules seem to be more restricted by the fat cell concentra-
tion than trabecular bone. When marrow fat content (80%-94%) is very
high, that is in saturation condition like in calcaneal bone marrow (our
case), ADC parameter becomes again sensible to the intertrabecular
spaces created by trabecular bone density decreasing.
Taking into consideration the whole calcaneus and its regions
only, in which it was evaluated the Mfc, in the Fig. 5.4 it is possible
to notice that for low or intermediate bone density, ADC values de-
crease as Mfc increases and this trend is higher for osteoporotic than
osteopenic group; the negative angular coefficients of the ADC regres-
sion straight lines are, in absolute values, higher in osteoporotic than in
osteopenic group. Thus, for low bone density and very highMfc values,
water molecules anyway seem restricted by the fat cell concentration.
In the same graphs, the straight lines of the three bone density groups,
obtained by the linear regression analysis, tend to a common interme-
diate ADC value at highest Mfc values, probably due to a free space
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saturation by fat cells.
In table 5.1, the mean ADC values of the three bone density
groups overlap when considering their SDs. Thus, the large standard
deviation (SD) associated with mean ADC values assessed in spongy
bone tissue from healthy, osteopenic and osteoporotic individuals does
not allow the clinical use of ADC on a single subject basis, but by the
last considerations, we can assert that the marrow fat content evalua-
tion might improve the diagnostic confidence of osteoporosis, by ADC
assessment of the calcaneal regions in subjects with lowest Mfc values.
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Figure 5.4: For each investigated region and for each group, ADC and
Mfc values of all postmenopausal subjects are plotted and examined by
linear correlation with their coefficients of determination (R2). (Normal:
-blue, osteopenia: -green, osteoporosis: N-red).
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6.1 State of the art
Magnetic resonance (MR) is a non-invasive technique which
is able to provide information on the relaxation and diffusion proper-
ties of water and fat protons from soft biological tissues such as bone
marrow. Therefore, when applied to the investigation of spongy bone,
MR provides information on bone marrow which is strictly linked to
the surrounding trabecular architecture of the bone due to the mutual
interaction between the solid matrix and liquid phase [94].
In this context, the apparent transverse relaxation time T ⋆2 was the first
MR parameter to be considered as a new surrogate marker for osteoporo-
sis. Indeed, T ⋆2 probes the micro-structure of TB due to its sensitivity
to the microscopic field in-homogeneities caused by magnetic suscepti-
bility differences between the solid bone structure and the liquid bone
marrow [95, 96]. The dephasing of the transverse magnetization due to
susceptibility differences produces a T ⋆2 shortening (see eqn. 3.22 and
3.20).
Several studies have consistently reported that, in different skeletal sites
such as the calcaneus, femoral neck and lumbar spine, an increase in
inter-trabecular space, which typically occurs in patients with osteo-
porosis, prolongs the corresponding T ⋆2 values [3, 97, 98]. Negative cor-
relations between T ⋆2 and BMD were also observed in the same different
skeletal sites [6, 7] and positive correlation between T ⋆2 and Age in the
lumbar spine of healthy subjects [97]. Moreover, Wehrli et al. measured
R⋆2 in the calcaneus and proximal femur of 68 women of varying spinal
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bone mineral density (BMD) and vertebral fracture status [3]: calcaneal
R⋆2, within each subject, was highly positively correlated to the femoral
R⋆2 and to the femoral and vertebral BMD; the strongest discriminator
of vertebral deformity was R⋆2 of the calcaneus, which was lower in the
fracture group, consistent with lower trabecular density; among the cal-
caneal sites examined, the ST region best discriminated the two groups,
with 77% diagnostic accuracy compared with 66% for vertebral BMD,
the cavum calcanei and the tuber calcanei also had significantly reduced
R⋆2 in the fracture group.
However, the large standard deviation (SD) associated with average T ⋆2
values assessed in bone tissue from healthy, osteopenic and osteoporotic
individuals does not allow the clinical use of T ⋆2 on a single subject ba-
sis [99]. The high inter-subject variability observed across studies is
likely to be due to differences in water/fat ratios which affect T ⋆2 decay.
Remarkably, higher values of T ⋆2 have been reported for fat as compared
to the water component, either in vitro [100,101] or in vivo [102]. Fur-
thermore, several kinds of fat molecules are present in bone tissue [103],
with relative concentration again varying across subjects.
In this chapter we propose an alternative way respect to T ⋆2
assessment, to quantify the influence of susceptibility changes in spongy
bone. The strategy is based on a new MR parameter (the internal gra-
dient Gi) that we demonstrate to be strictly associated with trabecular
bone TB density and structural rearrangements. Estimation of Gi can
be obtained by extraction of this parameter from the Spin-Echo (SE)
decay (see the subsection 3.3.1), which is traditionally used for the inves-
tigation of porous systems [104–106]. In a SE sequence, signal refocusing
is obtained by reversing the de-coherence effects of spins caused by the
distribution of local fields. This method is valid only when molecular
diffusion is not taken into account. Diffusion of liquid state protons in
local magnetic field gradients (internal gradients Gi) results in a more
than expected rapid loss of coherence from the usual spin-spin interac-
tion and surface effects [104, 107]. In SE measurements, the additional
decay of the echo amplitude is due to the diffusion of fluid molecules
in the local magnetic field gradient Gi generated by the difference in
magnetic susceptibility between bone marrow and solid bone plates. As
a consequence, in systems like spongy bone, it is possible to assess the
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intensity of Gi from the attenuation of SE decay. In spongy bone, Gi
values are not only affected by differences in magnetic susceptibility be-
tween bone marrow and solid bone plates, but also between fat and
water diffusion in TB marrow. Moreover, Gi depends on the orienta-
tion of the trabecular plates with respect to the external magnetic field
(see the subsection 3.3.1) [96, 108]. Some previous works have focused
on these Gi features in order to assess the preferential orientation of
trabeculae due to loading optimization [96, 109]. Recently, a new MR
approach based on the detection of spin diffusion through an internal
magnetic field gradient has been proposed to characterize TB [110,111].
This approach is based on measuring the Gi to encode diffusion weight-
ing to extract structural information (e.g., surface-to-volume ratio of
spongy-bone pores) from the resulting signal decay.
In all these situations, Gi seems to be a potential surrogate
marker reflecting different structural features of TB. They include not
only the solid phase density, but also other characteristics related to
spongy-bone quality (as expressed by water/fat concentrations within
the bone marrow).
The aim of the present work was to assess the potential ability
of Gi to describe spongy bone status as related to its TB density and
quality. For this purpose, using a micro-imaging probe we investigated
in vitro at high magnetic field (9.4 T) Gi behavior inside each single
pore of calf spongy-bone samples (extracted from a femur head) as a
function of both TB density and relative fat and water-bone marrow
concentrations. To test the methodological feasibility of this approach,
we first quantified mean Gi in calf samples characterized by different
TB densities. We then, investigated the potential suitability of Gi as a
measure able to assess the TB status in vivo. For this purpose, using
a 3T clinical scanner, we evaluated the Gi parameter, but also the T
⋆
2
and T2 parameters and their correlations with T -score, Mfc, ADC and
Age of the subjects, in calcaneus, in talus and in some their different
regions.
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6.2 In vitro experiments
6.2.1 Materials and methods
In vitro experiments were performed using a Bruker Avance-
400 high-resolution spectrometer operating at 9.4 T with a micro-imaging
probe (10 mm internal diameter), equipped with a gradient unit charac-
terized by a maximum gradient strength of 1200 mT m−1 and a rise time
of 100 µs. XWINNMRr and ParaVisionr 3.0 software were employed
for data acquisition and analysis.
Five ex vivo spongy-bone samples, excised from calf femur
head, were cut into pieces of approximately 20 mm high and 7 mm
deep in order to fit into the micro-imaging probe bore. The long axis
of each sample was located parallel to the main direction of the static
magnetic field (the z -axis). The temperature of each sample was fixed
to 291 K. T ⋆2 -weighted (Gradient Echo, GE) and T2-weighted (SE) im-
ages were obtained for initial evaluation of TB density. All samples were
characterized by a non-uniform trabecular density. As shown in figure
6.1, TB density varies continuously along the height of each sample,
moving from the upper to the lower zone. The upper zone, which is
close to the cortical bone, is characterized by higher trabecular density
and smaller spongy-bone pores (see Fig. 6.1(a)). Conversely, the lower
zone is characterized by a larger inter-trabecular space (see Fig. 6.1(c)).
The middle zone (located between upper and lower zones) shows inter-
mediate characteristics of TB density (see Fig. 6.1(b)). Throughout
the paper, we will refer to these three anatomical locations as follows:
(a) HTD (high trabecular density; upper zone), (b) ITD (intermediate
trabecular density; middle zone) and (c) LTD (lower trabecular density;
lower zone). In each sample, for each considered location, we identified
three 0.2 mm thickness slices to measure quantitative MR parameters.
Data extracted from each of the three slices were then averaged to ob-
tain mean values of each MR parameter in the three locations (HTD,
ITD and LTD). Five analyzed samples were selected such that they
were characterized by similar TB densities and similar fat-to-water ra-
tio quantities in bone marrow. TB density and bone marrow water
content (together with the relative content of different types of fat in
bone marrow) are known to be dependent on age, race and skeletal
Chapter 6: Internal gradient 103
Figure 6.1: An example of the calf spongy-bone sample used for experi-
ments in vitro [112]. GE localizer and SE images (TE=4.3 ms) selected
perpendicularly to the static magnetic field at three different depths in
the sample show a non-uniform TB density. In each experimental sam-
ple, trabeculae are closely spaced in the upper zone (a). Conversely,
they show an intermediate density in the middle zone (b) and a larger
inter-trabecular space in the lower zone (c).
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site. To correct for these potential biases, we obtained all our samples
from 10- to 12-month-old calves of German race, bred in Germany and
butchered in Rome (Italy). In all fresh samples (analyzed immediately
after slaughter) we identified the same area of the femur head for MR
investigation.
In the first step of our experiments, a validation experiment
was performed under ideal circumstances where molecular diffusion and
T2 information were obtained for each of the two individual spectral
components (water and fat molecules). A spectroscopic Carr-Purcell-
Meiboom-Gill (CPMG, repetition time TR=1 s, number of averaged
scans NS=8, N=64 data points, (corresponding to 64 echoes refocusing
every 2 ms from 1 to 127 ms) and a spectroscopic pulsed field gradient
stimulated echo (PGSE, TE/TR=18/3000 ms, diffusion gradient pulses
delay ∆=400 ms, diffusion gradient pulses duration δ=4.6 ms and dif-
fusion gradient strength g applied along the x -axis using 32 gradient
amplitude steps from 6 to 100 mT m−1) were used to recognize and
discriminate T2 and ADC of water and fat molecules in the samples.
A MSME (multi-slice multi-echo) imaging sequence (TR=2000
ms, field of view FOV=7 mm, matrix 256x256, slice thickness STH=0.2
mm, pixel dimensions 27x27 µm2, NS=8) at various TE s (4.8, 6, 8, 10,
12, 14, 16, 18, 20, 24, 30, 40, 50, 60, 70, 80, 100, 120 ms) was used to
obtain the SE decay in the three regions of each sample characterized by
a different TB density. A PGSTE imaging sequence was also employed
(TE/TR=21.9/3000 ms, FOV=7 mm, matrix 256x256, ∆=40 ms, δ=4
ms, using eight b values ranging from 400 to 40000 s mm−2, STH=0.2
mm, NS=8) in order to measure the ADC along the x -axis for each
of the three selected regions of the considered samples. The b value is
related to the aforementioned parameters through the known relation:
b = γ2g2δ2(∆ − δ/3), where g is the diffusion gradient strength. The
x -axis was arbitrarily chosen to assess molecular diffusion perpendicular
to trabeculae surfaces (see Fig. 6.1).
After the micro-imaging investigation of the bone marrow’s wa-
ter and fat behavior within pores of spongy bone, we set up an equivalent
acquisition protocol at lower TE s (4.8, 10, 20, 40, 60, 80, 100 ms) and
b values (ranging from 200 to 10000 s mm−2). This additional protocol
was added to obtain a protocol potentially suitable for clinical applica-
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tion (i.e. lower scan time, lower b values). However, due to a reduced
number of experimental points, this acquisition provides SE decays and
ADCs that do not clearly discriminate between water and fat.
T2 and ADC of water and fat components were obtained us-
ing a Levenberg-Marquardt (L-M) fit taking into account the peak area
decays respectively centered at 4.7 ppm (large from 4 to 5.4 ppm) for
water and at 1.3 ppm (large from 0.1 to 2.5 ppm) for fat. Due to the
low resolution of bone marrow spectra in the spongy-bone samples, the
olefinic fat peak at 5.3 ppm overlaps the broad water peak centered at
4.7 ppm. For this reason, we fitted the attenuation of this broad peak
(from 6 to 4 ppm) versus the diffusion gradient strength or the TE value
using a bi-exponential function. This took into account the olefinic and
water component separately. In figure 6.2 an example of spectroscopic
investigation is shown.
Two different in vitro analyzes were performed using the data
extracted from the imaging experiments. In both cases we considered
only the central zone of each image (i.e. excluding the image border),
in order to exclude or limit the presence of air in bone marrow cavities.
Indeed, this represents one of the major sources of artifacts when per-
forming imaging on excised samples.
In the first analysis, the signal deriving from water and fat
protons in T2-weighted images was investigated as a function of each
voxel location with respect to the bone-bone marrow interface. In each
slice of the three considered locations, the signal nearby the boundaries
between bone marrow and solid bone was identified using a software
(written in Matlab) (see Fig. 6.3) written in-house.
SE signal properties and Gi behavior were then assessed in
the boundary and inner regions of the trabecular pores. The inner re-
gions of the pores were identified by subtracting the boundary regions
from the whole pore area. An L-M fit was performed using the signal
as a superimposition of two components: one belonging to fats and an-
other belonging to water molecules. Each component contributes to the
total signal as one exponential term of formula 3.23 (the second part
of formula). The signal intensity at TE=0, T true2 , Gi and the ADC of
water and of fat components were obtained. Using this procedure, mean
and SD values of Gi from water and fat were respectively derived. Wa-
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Figure 6.2: An example of the fitting procedure used in spectroscopic
validation experiments to obtain T2 and ADC of water and fat compo-
nents [112]. The broad peak on the left side of the spectrum is characteri-
zed by two different components: water centered at 4.7 ppm and olefinic
fat centered at 5.3 ppm. Peak attenuation versus gradient strength or
TE value was fitted using a bi-exponential function which took into
account olefinic and water components separately. Conversely, the at-
tenuation of fat peak at 1.3 ppm (on the right side of the spectrum) was
fitted using monoexponential functions.
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Figure 6.3: Example of selection of a three pixel wide boundary region in
three considered locations, respectively, characterized by lower (LTD),
intermediate (ITD), and higher trabecular density (HTD) [112]. The
red mask, which represents the boundary region, is superimposed over
SE images obtained at TE=4.3 ms.
ter ADC and fat ADC were measured from diffusion-weighted images,
while T true2 values were considered a free parameter in the fit.
Conventional T2 relaxation times of water and fat components
were also evaluated from the same images, executing a bi-exponential
L-M fit of water and fat components, in accordance with formula 3.23
(the first part of formula). This analysis was repeated at different widths
(measured in voxels) from the boundary region of each pore. The mean
values of water and fat Gi were calculated by averaging the results ob-
tained in all pores contained in three image slices for each specific loca-
tion (HTD, ITD and LTD).
In order to have a more objective quantification of TB den-
sity, we calculated the ratio between the perimeter and the area of each
pore in the slices. As a result, the ratio (Np/Na) between the number
of voxels defining each pore perimeter (Np) and the number of voxels
constituting the corresponding area (Na) was obtained from all pores
included in each of the slices. Then, the mean values of Np/Na and Gi
in different bone locations (characterized by different TB densities as
defined by Np/Na) were obtained from each sample. Moreover, mean
values of both magnetization associated with water and fat extracted
from the bi-exponential fit as a function of the boundary region width
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were evaluated. The averages were calculated in all five samples. Pear-
son’s correlation coefficient (r) and a paired Student’s t-test were used
to assess the linear correlation between Gi and TB densities and differ-
ences between water and fat magnetization as a function of boundary
distances measured in voxels.
In a second experiment, Gi was derived using the signal arising
from each entire slice. In this case, we aimed to identify an acquisition
protocol at high magnetic field which might also be suitable for clin-
ical application (using relatively short acquisition times, conventional
sequences and a lower image resolution compared to that obtained by
micro-imaging apparatus). Distinguishing water from fat components
was not a priority in this case. Therefore, a monoexponential L-M fit
was employed to obtain the mean ADC along the x -axis. A monoex-
ponential L-M fit was performed using formula 3.23 (the second part of
formula) and included a constant which took into account the deviation
from monoexponential behavior. Mean and SD values of Gi were ob-
tained in the three bone locations (HTD, ITD and LTD) performing an
average of Gi values across the five samples together with their corre-
sponding values of T true2 . Moreover, conventional T2 relaxation time was
estimated from each slice using a monoexponential L-M fit as described
by formula 3.23 (the first part of formula) plus a constant. Again, mean
and SD values of T2 were obtained in the three zones (HTD, ITD and
LTD) by performing an average of T2 values across the five samples.
6.2.2 Results and discussion
Spectroscopic T2 and ADC mean values and their SD of water
and fat components in excised bone samples are reported in table 6.1.
(T2 ± SD)(ms) (ADC ± SD)(m
2/s)
H2O at 4.7 ppm 19 ± 7 (4.2 ± 1.8)E-10
Fats at 5.3 ppm 72 ± 36 (5.0 ± 0.6)E-12
Fats at 1.3 ppm 65 ± 16 (5.3 ± 0.3)E-12
Table 6.1: Spectroscopic evaluation of excised calf samples [112].
Data show that T2 and ADC of the water component (centered at 4.7
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(a) Water component
Water (T2 ± SD) (ADC ± SD) (Gi ± SD) (T
true
2
± SD)
(%) (ms) (m2/s) (mT/m) (ms)
LTD 55 17.0 ± 3.0 (19.0 ± 0.4)E-10 222 ± 131 17.9 ± 1.0
ITD 47 15.0 ± 2.3 (7.0 ± 0.4)E-10 282 ± 134 15.2 ± 0.5
HTD 97 14.8 ± 0.4 (1.6 ± 0.1)E-10 803 ± 181 16.0 ± 0.3
(b) Fat component
Fat (T2 ± SD) (ADC ± SD) (Gi ± SD) (T
true
2
± SD)
(%) (ms) (m2/s) (mT/m) (ms)
LTD 45 42.3 ± 6.2 (5.3 ± 0.3)E-12 760 ± 195 43.0 ± 4.8
ITD 53 39.7 ± 4.0 (5.9 ± 0.3)E-12 727 ± 437 44.0 ± 5.3
HTD 3 31.6 ± 6.0 (5.4 ± 0.2)E-12 904 ± 119 37.5 ± 9.8
Table 6.2: Results from one excised calf sample: (a) water component
and (b) fat component [112].
ppm) are significantly lower and higher respectively than those of fat
components (centered at 5.3 ppm and 1.3 ppm). This allows us to dis-
criminate clearly between the two components (water and fat). Specif-
ically, T2 values of water and fat are respectively consistent with those
previously reported [113]. Similarly, ADCs of fat components, which
are approximately two order of magnitude lower than those of water
molecules, fit well with those recently reported by other authors [114].
In table 6.2, mean values (and their SD) of T2, ADC, Gi and
T true2 are reported for the water component obtained in LTD, ITD and
HTD locations of one sample (performing an average of values extracted
from each slice belonging to a single location). In table 6.2, the corre-
sponding results for the fat component are reported. The water ADC
showed a decreasing trend proportional to the increase of trabecular
density; thus, water mobility is more restricted in regions where the
trabeculae are smaller. Conversely, it is evident from table 6.2 that the
fat ADC is not sensitive to increase in trabecular density. Water Gi
increases proportionally with the increase in TB density, while fat Gi
is characterized by an opposite trend and does not allow discrimination
between LTD and ITD.
Figure 6.4 displays different types of behavior of water and fat
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Gi as a function of the distance (in voxels) between the TB marrow
interface and the internal part of the trabecular pore. Gi values were
derived using a fitting procedure, while ADC values were derived from
diffusion-weighted images. According to our findings, water Gi is cha-
Figure 6.4: Behavior of water (left) and fat Gi (right) as a function of
increasing voxel number ranging from regions with one pixel (located
close to the bone surface) to regions constituted by five pixels (from
the bone surface to the pore center) [112]. Results are reported for
HTD (empty squares), ITD (empty circles) and LTD (filled circles). In
regions with HTD, the last two points are missing because the trabecular
interspaces were not large enough to allow a boundary region (which is
wider than three pixels) to be drawn.
racterized by a decreasing trend when moving from zones adjacent to
the trabecula to zones located in the center of the inter-trabecular space.
This behavior was observed in each of the three locations characterized
by different TB densities. When comparing Gi magnitude between the
three locations, it was otherwise evident that Gi in the HTD location
is higher than that extracted from the other two locations (ITD and
LTD). Conversely, fat compared to water Gi revealed an opposite be-
havior. In the latter case, Gi was characterized by an increasing trend
when moving from voxels adjacent to trabeculae to those located in the
center of the inter-trabecular space. In the insets of figure 6.4, mean
magnetization intensities are reported for fat and water components as
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derived from the fitting procedure. Water concentration is higher in the
HTD slices and decreases proportionally with the reduction of trabecu-
lar density (i.e. in ITD and in LTD).
ADC values and their magnetic susceptibility are the key pa-
rameters accounting for the different types of behavior of water and fat
Gi (see Fig. 6.4 and 6.5). The water ADC is approximately two or-
ders of magnitude higher than the fat ADC. As a consequence, water
molecules compared to fat molecules are characterized by a faster mo-
tion. According to Einstein’s relation 〈r〉2 = 2Dt, which links the mean
square spatial range spanned by diffusing molecules (characterized by a
certain diffusion coefficient D at a diffusion time t), water spins travel a
distance of the order of tenths of microns (calculated using the diffusion
times ∆ employed in this study). Conversely, the displacement of pro-
tons in fat lies in the sub-micron range. Moreover, water and fat are cha-
racterized by different magnetic susceptibilities: χwater = −9.05x10−6
and χfat = −8.44x10−6 (SI units) [115], while bone tissue is believed to
be characterized by χbone = −11x10−6 [116].
The Gi belonging to protons in water is sensitive to differences
in magnetic susceptibility in the range of the pixel dimension. As ex-
pected, Gi shows a decreasing trend when moving from the bone-bone
marrow interface to the pore center. Indeed, the difference in water-
bone susceptibility represents the main source of water Gi. Conversely,
protons in fat are sensitive to differences in magnetic susceptibility rang-
ing at least from two orders of magnitude less than the pixel size. For
this reason, fat Gi measured in this study cannot be attributed to the
bone-bone marrow interface. Fat Gi magnitude is better explained by
the difference in magnetic susceptibility between fat and water. The
increasing trend of fat Gi values (when moving from the bone-bone
marrow interface to the pore center) can thus be ascribed to a different
rearrangement of fat molecules. In the central zone of each pore, there is
a higher concentration of fat molecules characterized by a lower molec-
ular motion than that of water molecules. As a consequence, fat Gi in
the center of the pore assumes higher values than those observed nearby
the bone surface. Indeed, in this latter location, there is a reduced con-
centration of fat molecules. This means that a correspondingly higher
concentration of water molecules (characterized by faster motion) mod-
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ulates fat Gi by reducing its values. This scenario fits well with the
hypothesized distribution of bone marrow filling trabecular pores, for
which we could say that ’water wets’ the surface of bone pores. On the
other hand, fat molecules, due to their hydrophobic nature, are mainly
rearranged to lie in the central zone of the pore. As shown in figure 6.5,
water and fat Gi behavior in the boundary and inner regions of LTD
pores support this hypothesis. In the figure, water and fat Gi behavior
Figure 6.5: Water Gi (left) and fat Gi (right) behavior for LTD in the
boundary region (filled circles) and in the inner region (empty circles)
as a function of increasing boundary region width (which corresponds
to a decrease of the inner region width) [112]. The size of each pixel is
27 µm.
(expressed as a function of increasing pixel width) of the boundary re-
gion are compared to those measured from the inner region. Gi values
of both water and fat bone marrow components move toward an asymp-
totic value which is very close to that obtained in the central zone of
the trabecular pore.
This observation confirms that water Gi variation is mainly due
to bone-bone marrow interface susceptibility properties. Therefore, wa-
ter Gi might be considered as a surrogate marker of the TB structure.
The asymptotic Gi values reached by the fat component were higher
when compared to those reached by the water component. Again, the
difference in the diffusion coefficient between fat and water might ex-
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plain these results. As water molecules, compared to fat molecules, are
associated with a faster diffusive motion during the experimental diffu-
sion time, water spins are more dependent on motional averaging. As
a consequence, the susceptibility dephasing effect which affects the SE
signal of water is partially averaged. This peculiar behavior of water/fat
systems has already been investigated and verified elsewhere [117]. To
support the hypothesis that water concentration is higher in the bound-
ary zone of pores, while fat is more concentrated in the central zone of
pores, mean magnetization, extracted from the fit and associated with
water (left) and fat (right) quantities in the first three voxels of the
boundary regions, is reported in figure 6.6. Mean magnetization values
Figure 6.6: Mean magnetization values arising from the bi-exponential
fit associated with water (left) and fat (right) versus boundary region
width, expressed as a distance in voxels from the bone/marrow boundary
[112]. The average is performed across all samples. LTD location was
considered in all experimental samples.
and their corresponding SD values were obtained from all five samples
belonging to different calves. Mean magnetization values associated
with each voxel’s zone of the boundary region are statistically different
(p=0.05).
Data reported in figure 6.6 demonstrate that in each pore of
spongy bone, the quantities of water molecules at the bone-bone mar-
row interface are higher than that of fat molecules. As a consequence,
in spongy bone (filled with bone marrow), the measurements of water
MR parameters (such as Gi, T
⋆
2 or ADC) best provide information on
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TB density.
In figure 6.7 mean Gi values and their SD, obtained from the
five samples as a function of their TB density, are reported. The graph
in the inset of figure 6.7 shows a positive linear correlation between wa-
ter Gi and TB densities (Pearson’s correlation coefficient r = 0.71). The
Figure 6.7: Water Gi behavior (empty circles) and fat Gi behavior (filled
circles) as a function of trabecular density obtained as the ratio between
the number of voxels belonging to the boundary perimeter (Np) and the
number of voxels of the whole area (Na) [112]. The mean Gi values were
calculated in a boundary region of three voxels wide. In the figure inset
a zoom is displayed for TB densities ranging from 0.25 to 0.34.
large SD associated with water Gi mean values is mainly due to differ-
ences in water content between the five samples. The strong variation
of water ADC is likely due to the small differences in water-fat content
percentages across samples. The smaller are the ADC SDs, the larger
are the SDs of Gi. Conversely, the fat ADC changes less as a function
of water-fat percentage variation.
Finally, T2, ADC, Gi and T
true
2 mean values and their SDs
obtained from the entire slice area from each of the selected locations
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(T2 ± SD) (ADC ± SD) (Gi ± SD) (T
true
2
± SD)
(ms) (m2/s) (mT/m) (ms)
LTD 22.6 ± 9.7 (4.0 ± 0.7)E-10 263 ± 68 30.7 ± 3.3
ITD 22.0 ± 5.7 (3.8 ± 1.2)E-10 411 ± 102 28.1 ± 2.9
HTD 8.7 ± 2.8 (5.3 ± 1.6)E-10 675 ± 183 8.3 ± 1.2
Table 6.3: Results obtained from excised calf samples without discrim-
inating between water and fat [112].
(averaging on the five samples) are reported in table 6.3. Gi and T
true
2
were extracted from the fit by function 3.23 (the second part of for-
mula), while T2 and ADC represent values obtained by direct measures.
Results reported in table 6.3 are from an additional analysis in which
we did not discriminate between fat and water components. This means
that both components contribute, with different modalities, to the total
fitted signal. However, the acquisition parameters chosen for this ex-
periment were intentionally optimized to focus on the water signal (for
example, b values from 0 to 10 000 s mm−2 were chosen to detect the
typical water ADC but not the fat ADC). This means that there is
only a minimal weight of the fat component in the determined results
reported in table 6.3.
T2 and ADC values did not discriminate between LTD, ITD
and HTD. Conversely, T true2 was characterized by a decreasing trend
when moving from LTD to HTD, while Gi showed different values in
the three locations with different TB densities. In bone marrow, T2
is mainly dependent on the relative proportion of fat and water pro-
tons (which are characterized by different transverse relaxation times),
as well as from the TB density. The ADC depends on the intersti-
tial spaces between bone and fat where water diffuses. Gi assumes a
higher value for higher trabecular densities, as expected by water Gi
values reported in table 6.3, which are due to differences in magnetic
susceptibility at the bone-water interface. Results reported in table 6.3
represent a preliminary test at high field to investigate the feasibility of
including Gi measurements within clinical protocols (i.e. collection of
T2- weighted images and ADC maps). Gi would add useful information
by discriminating between different TB densities.
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6.3 In vivo experiments
6.3.1 Materials and methods
For every volunteer (see section 4.2), we acquired sagittal view
images obtained on the same slices (5 mm thickness) and by using the
same foot position. FLASH (Fast Low Angle Shot) images and MCSE
(Multi Contrast Spin Echo) images at various TE s were acquired to
evaluate T ⋆2 and T2 respectively. The imaging parameters used for
MCSE images at 3.0 T were: TE (echo time)=20,30,40,50,80,100 ms,
BW (bandwidth)= 130 Hz/pixel, square FOV (field of view)=192 mm,
matrix=256x256, resolution=0.75x0.75x5 mm3; while for FLASH im-
ages the following parameters were used at 3.0 T: FA (flip angle)=30◦,
TE=5,7,10,20 ms, BW=260 Hz/pixel, square FOV=192 mm, matrix=
128x128, resolution=1.5x1.5x5 mm3. Finally TR (repetition time)=1500
ms and NS (number of scan)=1 were used in all acquisitions.
We focused our attention on the whole calcaneus, the whole
talus and on the AC, ST, TC and CC regions (see section 5.2). T ⋆2
and T2 from FLASH and MCSE images, respectively were obtained by
performing a mono-exponential fit of the mean intensities of every se-
lected ROI at the different TE s (see formula 3.21 for T ⋆2 evaluation; see
the first part of formula 3.23 for T2 evaluation). From MCSE images,
the equation 3.23 (the second part of formula), with four parameters
to estimate (the signal intensity at TE=0, T true2 , Ω =
1
12γ
2G2iD and
an additive constant), was fitted by a complex mono-exponential curve
with the mean intensities of every selected ROI at the different TE s;
with one of these estimated parameters (Ω), the internal gradient (Gi)
of each ROI was calculated by substituting the correspondent measured
ADC value (see section 5.3). A modified Levenberg-Marquardt nonlin-
ear regression fit-type function was used.
T ⋆2 , T2 and Gi values of each region, were averaged across the
subjects for each bone density group (normal, osteopenia and osteoporo-
sis, labeled 1, 2 and 3 respectively) and for the control group (labeled
C ) and their standard deviations were calculated. T ⋆2 , T2 and Gi val-
ues from postmenopausal women were also graphed, for each region,
with their averages and were plotted versus marrow fat content Mfc
values obtained in the previous chapter (see section 4.3). For each re-
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gion, the mean T ⋆2 , T2 and Gi values were compared among the three
bone density groups and between the control and normal group with the
one-way analysis of variance test (one-way ANOVA) and Pearson cor-
relation coefficients (r) were calculated to assess the linear relationship
between pairs of variables (among T -score, Age, Mfc, ADC, T ⋆2 , T2
and Gi variables) for all postmenopausal subjects and for all subjects of
each bone density group. A p value of less than 0.05 was considered to
indicate a statistically significant difference.
6.3.2 Results and discussion
Osteoporosis induces an increase in trabecular bone spacing,
observable with an increase in bone marrow MR signal intensity (see
Fig. 6.8), which reduces the spatial field inhomogeneity and thus con-
siderably prolongs T ⋆2 and Gi (see eqn. 3.24).
The results reported in Tab. 6.4 and in the graphs in Fig. 6.9
Figure 6.8: Sagittal high resolution FLASH images at 3.0 T of calcaneus
of two elderly women (60-years-old and normal bone density with T-
score=-0.1 on the left and 67 and osteoporotic with T-score=-4.61 on the
right) showing the higher bone marrow signal intensity in osteoporotic
than in normal person, due to the higher trabecular bone spacing.
show that the mean T ⋆2 values of the three bone density groups increase
as bone density decreases and these differences are statistically signifi-
cant among the three groups in AT, CC and CALCA regions; AT, CC
and CALCA are the only regions with statistically significant discrimi-
nation between normal and osteopenic group and CALCA is the best;
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TC is the only region without statistically significant discrimination be-
tween osteopenic and osteoporotic group and ST is the best region to
discriminate between these groups. Our mean T ⋆2 values in every cal-
caneal region agree with literature findings [3].
As is possible to observe in Tab. 6.4 and in Fig. 6.10, the mean
T2 values have no trend as bone density decreases and there isn’t any
statistically significant discrimination between groups, probably due to
the poor dependence of the T2 parameter on the Gi and ADC factors
(see eqn. 3.23). Moreover, we can see that in Fig. 6.11 the mean Gi val-
ues of the three bone density groups decrease as bone density decreases
and these differences are statistically significant among the three groups
only in AT and ST regions; AT and ST are the only regions with
statistically significant discrimination between normal and osteopenic
group and ST is the best; TC and CC are, instead, the only regions
without statistically significant discrimination between osteopenic and
osteoporotic group and ST is the best region to discriminate between
these groups.
Conversely, T ⋆2 , T2 and Gi values almost always don’t point out any sta-
tistically significant difference between the control and normal group, in
every analyzed region.
Observing the results in Tab. 6.4, mean T ⋆2 and Gi values also
differ among calcaneal regions, in each group, being respectively highest
and intermediate in the cavum calcanei (the lowest trabecular bone den-
sity region), lowest and highest in the subtalar (the highest trabecular
bone density region) and intermediate and lowest values in the tuber
calcanei regions, thus these parameters (especially the T ⋆2 parameter)
give us information on local trabecular bone density. By their values,
they moreover locate higher trabecular bone density in the whole talus
than in the whole calcaneus and, instead, higher trabecular bone density
in ST than in AC region.
For paired data of all postmenopausal subjects, we ob-
tained a moderate significant negative correlation between T -score and
T ⋆2 in AC, AT , CALCA and ST regions (−0.564 ≤ r ≤ −0.515, p <
0.01) and a low significant negative correlation in all the other ana-
lyzed regions (see Tab. 6.5 and 6.6); almost never significant correlation
between T -score and T2; a moderate significant positive correlation be-
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Figure 6.9: Graphs show T ⋆2 values, for three bone density groups (nor-
mal bone density, osteopenia, and osteoporosis), in the whole calcaneus
(CALCA), the whole talus (AT ) and in the ST, AC, TC and CC re-
gions. Mean T ⋆2 values increase as bone density decreases; AT, CC and
CALCA are the only regions with statistically significant discrimination
between normal and osteopenic group and CALCA is the best; TC is
the only region without statistically significant discrimination between
osteopenic and osteoporotic group and ST is the best region to discrimi-
nate between these groups. Horizontal bar = mean value for each group
(see Tab. 6.4). (Normal: -blue, osteopenia: -green, osteoporosis:
N-red).
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mal bone density, osteopenia, and osteoporosis), in the whole calcaneus
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gions. Mean T2 values have no trend as bone density decreases and
there isn’t any statistically significant discrimination between groups.
Horizontal bar = mean value for each group (see Tab. 6.4). (Normal:
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Chapter 6: Internal gradient 121
195
295
395
495
595
695
795
895
995
1095
G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
CALCA-Gi
150
250
350
450
550
650
750
850
950
G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
AT-Gi
170
270
370
470
570
670
770
870
G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
ST-Gi
150
250
350
450
550
650
750
850
950
G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
AC-Gi
100
250
400
550
700
850
1000
1150
T
C
-G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
TC-Gi
100
200
300
400
500
600
700
800
900
1000
C
C
-G
i
(m
T
/m
)
Normal Osteopenia Osteoporosis
CC-Gi
Figure 6.11: Graphs show Gi values, for three bone density groups (nor-
mal bone density, osteopenia, and osteoporosis), in the whole calcaneus
(CALCA), the whole talus (AT ) and in the ST, AC, TC and CC re-
gions. Mean Gi values decrease as bone density decreases; AT and
ST are the only regions with statistically significant discrimination be-
tween normal and osteopenic group and ST is the best; TC and CC are
the only regions without statistically significant discrimination between
osteopenic and osteoporotic group and ST is the best region to discrimi-
nate between these groups. Horizontal bar = mean value for each group
(see Tab. 6.4). (Normal: -blue, osteopenia: -green, osteoporosis:
N-red).
122 Chapter 6: Internal gradient
S
it
e
-P
a
r
a
m
e
t
e
r
R
a
n
k
in
g
C
1
2
3
p
v
a
lu
e
p
v
a
lu
e
p
v
a
lu
e
p
v
a
lu
e
(
1
-2
-3
)
(n
=
6
;
5
⋆
)
(n
=
1
2
;
8
⋆
)
(n
=
3
7
;
2
5
⋆
)
(n
=
2
8
;
2
2
⋆
)
(
C
v
s
1
)
(
1
v
s
2
)
(
2
v
s
3
)
(
1
v
s
3
)
A
C
-T
⋆2
(
m
s
)
U
6
.9
4
±
0
.9
3
6
.9
2
±
1
.0
4
7
.8
9
±
1
.6
3
9
.0
8
±
1
.9
0
n
s
n
s
∗
∗
∗
∗
A
C
-T
2
(
m
s
)
N
3
1
.0
2
±
4
.5
5
3
7
.2
6
±
5
.2
8
3
3
.7
7
±
6
.0
7
3
5
.6
3
±
7
.0
4
∗
n
s
n
s
n
s
A
C
-G
i
(
m
T
/
m
)
D
5
0
2
.8
4
±
2
0
4
.4
9
5
3
4
.1
2
±
1
6
3
.0
6
4
3
7
.2
0
±
1
7
1
.9
4
3
3
7
.2
5
±
1
2
9
.4
3
n
s
n
s
∗
∗
∗
A
T
-T
⋆2
(
m
s
)
U
6
.8
8
±
1
.0
2
7
.3
0
±
1
.0
5
8
.6
1
±
1
.6
8
9
.8
1
±
1
.6
7
n
s
∗
∗
∗
∗
∗
∗
A
T
-T
2
(
m
s
)
N
3
1
.4
5
±
4
.1
5
4
0
.3
7
±
4
.1
9
3
8
.1
3
±
5
.0
0
3
9
.8
8
±
4
.5
0
∗
∗
n
s
n
s
n
s
A
T
-G
i
(
m
T
/
m
)
D
5
0
2
.0
4
±
2
5
0
.6
7
6
1
7
.7
5
±
1
6
9
.7
2
4
5
0
.8
8
±
1
3
8
.8
6
3
5
6
.5
6
±
1
1
0
.4
7
n
s
∗
∗
∗
∗
∗
∗
S
T
-T
⋆2
(
m
s
)
U
5
.3
1
±
0
.7
9
5
.7
0
±
1
.1
5
6
.4
9
±
1
.1
8
7
.7
2
±
1
.3
6
n
s
n
s
∗
∗
∗
∗
∗
∗
S
T
-T
2
(
m
s
)
N
3
5
.7
9
±
2
.7
2
3
7
.5
0
±
1
.9
0
3
6
.7
6
±
3
.7
2
3
7
.8
5
±
3
.6
7
n
s
n
s
n
s
n
s
S
T
-G
i
(
m
T
/
m
)
D
5
6
2
.9
2
±
1
6
6
.6
9
6
2
3
.0
7
±
1
5
1
.6
6
4
1
3
.5
1
±
9
3
.0
5
3
2
5
.1
7
±
8
7
.1
9
n
s
∗
∗
∗
∗
∗
∗
∗
∗
T
C
-T
⋆2
(
m
s
)
U
1
0
.4
1
±
1
.7
2
1
0
.6
2
±
1
.5
2
1
2
.5
1
±
3
.6
7
1
4
.4
8
±
5
.0
4
n
s
n
s
n
s
∗
T
C
-T
2
(
m
s
)
N
3
8
.2
0
±
5
.7
5
3
7
.3
7
±
6
.0
9
3
8
.5
9
±
5
.5
4
3
8
.2
5
±
2
.5
4
n
s
n
s
n
s
n
s
T
C
-G
i
(
m
T
/
m
)
D
3
5
5
.3
1
±
1
3
0
.9
7
4
6
4
.5
6
±
2
9
1
.3
0
3
4
8
.6
1
±
1
1
4
.6
1
2
8
7
.9
0
±
1
1
4
.1
6
n
s
n
s
n
s
∗
C
C
-T
⋆2
(
m
s
)
U
2
5
.7
4
±
6
.9
9
2
0
.9
7
±
5
.9
6
2
6
.3
6
±
7
.8
3
3
2
.3
7
±
9
.6
6
n
s
∗
∗
∗
∗
∗
C
C
-T
2
(
m
s
)
N
4
3
.4
4
±
6
.4
0
4
0
.8
6
±
2
.9
1
4
0
.8
2
±
6
.3
0
4
1
.9
6
±
6
.7
1
n
s
n
s
n
s
n
s
C
C
-G
i
(
m
T
/
m
)
D
5
5
0
.2
4
±
1
9
0
.8
2
4
7
3
.1
6
±
2
2
8
.5
9
4
0
9
.0
3
±
1
5
8
.2
6
3
1
7
.1
9
±
1
5
6
.1
1
n
s
n
s
n
s
∗
C
A
L
C
A
-T
⋆2
(
m
s
)
U
1
1
.0
7
±
1
.1
6
1
0
.4
7
±
1
.7
8
1
2
.4
8
±
2
.1
5
1
4
.1
8
±
2
.9
8
n
s
∗
∗
∗
∗
∗
∗
C
A
L
C
A
-T
2
(
m
s
)
N
4
0
.0
3
±
1
.9
5
3
9
.3
6
±
2
.6
0
3
9
.3
9
±
2
.7
5
4
0
.0
3
±
2
.3
7
n
s
n
s
n
s
n
s
C
A
L
C
A
-G
i
(
m
T
/
m
)
D
4
5
9
.9
6
±
5
4
.2
6
4
8
6
.2
0
±
1
7
9
.7
3
4
2
5
.1
3
±
1
4
7
.2
7
3
3
3
.8
4
±
1
0
0
.0
8
n
s
n
s
∗
∗
∗
T
ab
le
6.4:
T
h
e
m
ean
valu
es
of
T
⋆2 ,
T
2
an
d
G
i
variab
les,
w
ith
th
eir
stan
d
ard
d
ev
iation
s
are
rep
orted
for
th
e
con
trol
grou
p
an
d
for
each
b
on
e
d
en
sity
grou
p
.
T
h
e
com
p
arison
of
th
ese
valu
es
am
on
g
th
e
th
ree
b
on
e
d
en
sity
grou
p
s
an
d
b
etw
een
th
e
con
trol
an
d
n
orm
al
grou
p
,
b
y
p
valu
es
ob
tain
ed
w
ith
th
e
on
e-w
ay
an
aly
sis
of
varian
ce
test
(on
e-w
ay
A
N
O
V
A
),
an
d
th
eir
ran
k
in
g
tren
d
s
am
on
g
th
e
th
ree
b
on
e
d
en
sity
grou
p
s
are
also
rep
orted
.
N
otes:
1.
D
ata
are
m
ean±
1
stan
d
ard
d
ev
iation
;
2.
U
(u
p
w
ard
ran
k
in
g);
D
(d
ow
n
w
ard
ran
k
in
g);
N
(n
o
ran
k
in
g);
3.
C
(C
on
trol
grou
p
);
1
(N
orm
al);
2
(O
steop
en
ia);
3
(O
steop
orosis);
4.
n
s
(p
≥
0.05);∗
(p
<
0.05);∗∗
(p
<
0.01);∗∗∗
(p
<
0.001);
5.
A
C
(th
e
talar
region
close
to
calcan
eu
s);
A
T
(th
e
w
h
ole
talu
s);
S
T
(th
e
su
b
talar
region
of
calcan
eu
s);
T
C
(th
e
tu
b
er
calcan
ei
region
);
C
C
(th
e
cav
u
m
calcan
ei
region
);
C
A
L
C
A
(th
e
w
h
ole
calcan
eu
s);
6.
⋆
(n
u
m
b
er
of
su
b
jects
an
aly
zed
for
G
i
m
easu
res).
Chapter 6: Internal gradient 123
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
A
C
-T
⋆ 2
A
C
-T
2
A
C
-A
D
C
A
C
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.5
1
5
∗
∗
(3
)
0
.0
1
5
−
0
.3
1
6
∗
(2
)
0
.3
9
0
∗
∗
(2
)
A
g
e
1
0
.1
0
2
0
.1
7
0
0
.1
4
5
0
.1
5
5
−
0
.1
2
2
M
fc
1
0
.1
8
0
−
0
.0
6
4
−
0
.1
4
8
0
.1
2
4
A
C
-T
⋆ 2
1
−
0
.0
0
5
0
.1
2
4
−
0
.2
6
6
A
C
-T
2
1
−
0
.2
4
4
0
.5
8
0
∗
∗
(3
)
A
C
-A
D
C
1
−
0
.7
1
4
∗
∗
(4
)
A
C
-G
i
1
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
A
T
-T
⋆ 2
A
T
-T
2
A
T
-A
D
C
A
T
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.5
6
4
∗
∗
(3
)
−
0
.1
2
9
−
0
.3
7
6
∗
∗
(2
)
0
.5
0
1
∗
∗
(3
)
A
g
e
1
0
.1
0
2
0
.2
5
2
∗
(1
)
0
.1
5
8
0
.2
1
4
−
0
.2
3
5
M
fc
1
−
0
.0
0
6
−
0
.1
2
6
−
0
.1
6
3
0
.1
8
0
A
T
-T
⋆ 2
1
0
.3
3
1
∗
∗
(2
)
0
.0
2
6
−
0
.1
6
1
A
T
-T
2
1
−
0
.1
2
7
0
.3
5
1
∗
∗
(2
)
A
T
-A
D
C
1
−
0
.7
2
4
∗
∗
(4
)
A
T
-G
i
1
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
C
A
L
C
A
-T
⋆ 2
C
A
L
C
A
-T
2
C
A
L
C
A
-A
D
C
C
A
L
C
A
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.5
5
5
∗
∗
(3
)
−
0
.1
4
1
−
0
.4
6
3
∗
∗
(2
)
0
.3
1
8
∗
(2
)
A
g
e
1
0
.1
0
2
0
.1
3
3
−
0
.0
0
5
0
.1
0
8
−
0
.1
9
4
M
fc
1
0
.1
2
6
0
.0
0
6
−
0
.3
0
1
∗
(2
)
−
0
.0
4
8
C
A
L
C
A
-T
⋆ 2
1
0
.1
8
4
0
.2
4
5
0
.0
3
3
C
A
L
C
A
-T
2
1
0
.1
5
3
0
.0
5
9
C
A
L
C
A
-A
D
C
1
−
0
.5
4
1
∗
∗
(3
)
C
A
L
C
A
-G
i
1
T
ab
le
6.
5:
P
ea
rs
on
co
rr
el
at
io
n
co
effi
ci
en
t
te
st
re
su
lt
s
(r
)
b
et
w
ee
n
p
ai
rs
of
va
ri
ab
le
s
(a
m
on
g
T
-s
co
re
,
A
g
e,
M
f
c,
T
⋆ 2
,
T
2
,
A
D
C
an
d
G
i
va
ri
ab
le
s,
in
A
C
,
A
T
an
d
C
A
L
C
A
re
gi
on
s)
fo
r
al
l
p
os
tm
en
op
au
sa
l
su
b
je
ct
s.
N
ot
es
:
1.
D
at
a
ar
e
P
ea
rs
on
co
rr
el
at
io
n
co
effi
ci
en
ts
(r
);
2.
∗
(p
<
0.
05
);
∗∗
(p
<
0.
01
);
3.
(1
)
li
tt
le
(0
≤
r
≤0
.2
9)
,
(2
)
lo
w
(0
.3
≤
r
≤0
.4
9)
,
(3
)
m
o
d
er
at
e
(0
.5
≤
r
≤0
.6
9)
,
(4
)
h
ig
h
(0
.7
≤
r
≤0
.8
9)
,
(5
)
ve
ry
h
ig
h
(0
.9
≤
r
≤1
).
124 Chapter 6: Internal gradient
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
S
T
-T
⋆2
S
T
-T
2
S
T
-A
D
C
S
T
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.5
5
2
∗
∗
(3
)
−
0
.0
0
2
−
0
.4
8
8
∗
∗
(2
)
0
.6
3
5
∗
∗
(3
)
A
g
e
1
0
.1
0
2
0
.1
9
6
−
0
.0
6
7
0
.1
3
5
−
0
.3
0
6
∗
(2
)
M
fc
1
0
.1
0
2
0
.0
3
3
−
0
.2
5
0
0
.1
1
0
S
T
-T
⋆2
1
−
0
.0
2
8
0
.1
8
3
−
0
.2
1
7
S
T
-T
2
1
0
.0
2
3
−
0
.0
5
1
S
T
-A
D
C
1
−
0
.6
6
1
∗
∗
(3
)
S
T
-G
i
1
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
T
C
-T
⋆2
T
C
-T
2
T
C
-A
D
C
T
C
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.4
0
3
∗
∗
(2
)
−
0
.2
6
5
∗
(1
)
−
0
.3
5
0
∗
∗
(2
)
0
.3
0
5
∗
(2
)
A
g
e
1
0
.1
0
2
0
.1
6
7
0
.0
6
6
0
.1
0
0
−
0
.1
7
5
M
fc
1
0
.0
9
5
0
.1
3
5
−
0
.1
4
3
−
0
.0
5
0
T
C
-T
⋆2
1
0
.2
9
6
∗
∗
(2
)
0
.2
4
9
−
0
.1
2
1
T
C
-T
2
1
0
.0
4
8
0
.1
6
8
T
C
-A
D
C
1
−
0
.6
1
5
∗
∗
(3
)
T
C
-G
i
1
P
a
r
a
m
e
t
e
r
T
-s
c
o
r
e
A
g
e
M
fc
C
C
-T
⋆2
C
C
-T
2
C
C
-A
D
C
C
C
-G
i
T
-s
c
o
r
e
1
−
0
.4
2
5
∗
∗
(2
)
0
.0
8
0
−
0
.4
2
7
∗
∗
(2
)
−
0
.0
1
1
−
0
.4
9
7
∗
∗
(3
)
0
.3
4
1
∗
(2
)
A
g
e
1
0
.1
0
2
0
.1
9
2
−
0
.0
0
5
0
.1
7
7
−
0
.1
8
3
M
fc
1
0
.1
5
0
0
.1
4
2
−
0
.2
4
8
0
.1
0
9
C
C
-T
⋆2
1
0
.2
6
8
∗
(1
)
0
.1
7
7
0
.0
6
6
C
C
-T
2
1
−
0
.0
5
1
0
.3
1
7
∗
(2
)
C
C
-A
D
C
1
−
0
.6
0
3
∗
∗
(3
)
C
C
-G
i
1
T
ab
le
6.6:
P
earson
correlation
co
effi
cien
t
test
resu
lts
(r
)
b
etw
een
p
airs
of
variab
les
(am
on
g
T
-score,
A
g
e,
M
f
c,
T
⋆2 ,
T
2 ,
A
D
C
an
d
G
i
variab
les,
in
S
T
,
T
C
an
d
C
C
region
s)
for
all
p
ostm
en
op
au
sal
su
b
jects.
N
otes:
1.
D
ata
are
P
earson
correlation
co
effi
cien
ts
(r
);
2.
∗
(p
<
0.05);∗∗
(p
<
0.01);
3.
(1)
little
(0≤
r
≤
0.29),
(2)
low
(0.3≤
r
≤
0.49),
(3)
m
o
d
erate
(0.5≤
r
≤
0.69),
(4)
h
igh
(0.7≤
r
≤
0.89),
(5)
very
h
igh
(0.9≤
r
≤
1).
Chapter 6: Internal gradient 125
tween T -score and Gi in AT and ST regions (0.501 ≤ r ≤ 0.635, p
< 0.01) and a low significant positive correlation in all the other an-
alyzed regions. Even if T ⋆2 and Gi parameters are able to distinguish
the three bone density groups, according to WHO criteria, they have
a low or moderate significant correlation with T -score values and this
demonstrates that they don’t depend only on the bone density but also
on other factors bound to the bone quality, as previous asserted. No
significant correlation between the three parameters (T ⋆2 , T2 and Gi)
and Mfc and almost never significant correlation between them and
Age (only a positive little for T ⋆2 in AT and a negative low for Gi in
ST ) was observed. A high significant negative correlation between Mfc
and Gi was obtained in TC region (r = −0.776, p < 0.05) and in the
whole calcaneus for the normal postmenopausal subjects (r = −0.733,
p < 0.05) and in the whole calcaneus for the control group (r = −0.88,
p < 0.05). Moreover, a high significant negative correlation between Gi
and ADC was obtained in AC and AT regions and a moderate in all
the other regions.
In Fig. 6.12 it is possible to notice that for low bone density,
T ⋆2 values increase as Mfc increases; for high bone density, T
⋆
2 values
almost always instead decrease as Mfc increases.
Taking into consideration the whole calcaneus and its regions only, in
which it was evaluated the Mfc, in the Fig. 6.13 it is possible to notice
that for high bone density, Gi values decrease as Mfc increases; for
low bone density, Gi values instead increase as Mfc increases. Thus,
for high bone density, as the marrow fat content increases, the linked
trabecular bone density and the spatial magnetic field inhomogeneities
decreases, so the Gi decreases; for low bone density, Gi parameter seems
to become more sensible to the local magnetic susceptibility differences
between the solid matrix of trabecular bone and the interstitial liq-
uid bone marrow, because as the bone marrow fat component increases,
these local differences and therefore the local Gi increase (see subsection
6.2.2). In the same graphs, the straight lines of the three bone density
groups, obtained by the linear regression analysis, tend to a common
intermediate Gi value at highest Mfc values.
In table 6.4, the mean T ⋆2 values of the three bone density
groups overlap when considering their SDs; the mean Gi values almost
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always have the same behavior, only its values of the normal and os-
teoporotic groups in ST region don’t overlap. Thus, as aforementioned,
the large standard deviation associated with mean T ⋆2 and Gi values as-
sessed in spongy bone tissue from healthy, osteopenic and osteoporotic
individuals does not allow the clinical use of T ⋆2 and Gi on a single
subject basis. According to our experimental results, T ⋆2 turned out to
be affected by the marrow fat content, a parameter that shows a huge
spread across different subjects. Some authors have suggested introduc-
ing corrections to account for variations in marrow composition [69].
However, to our knowledge, no-clinical studies involving these correc-
tions have been published so far. As for the ADC parameter, by the
last considerations, we instead can assert that the marrow fat content
evaluation might improve the diagnostic confidence of osteoporosis, by
Gi assessment of the calcaneal regions in subjects with lowest Mfc val-
ues.
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Figure 6.12: For each investigated region and for each group, T ⋆2 and
Mfc values of all postmenopausal subjects are plotted and examined by
linear correlation with their coefficients of determination (R2). (Normal:
-blue, osteopenia: -green, osteoporosis: N-red).
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Figure 6.13: For each investigated region and for each group, Gi and
Mfc values of all postmenopausal subjects are plotted and examined by
linear correlation with their coefficients of determination (R2). (Normal:
-blue, osteopenia: -green, osteoporosis: N-red).
Chapter 7
The best Site-Parameter
In this chapter, analyzing the obtained results, we want to
compare the potential ability of T ⋆2 , T2, ADC and Gi parameters to dis-
criminate among healthy, osteopenic and osteoporotic individuals; then,
by this evaluation we want to indicate the best parameter and the best
heel spongy bone site by which to obtain the best discrimination.
Moreover, by a deeper analysis than the simple linear correlation, we
want to identify the site-parameter couple which best classifies the sub-
jects in the same way of T -score.
7.1 T ⋆2 , T2, ADC, Gi comparisons
To make the right comparisons, we summarize in table 7.1
the results obtained in tables 5.1 and 6.4 and associate to each site-
parameter a discrimination code abc with a relative to the comparison
of 1-2 groups (normal vs osteopenia), b for 2-3 groups (osteopenia vs
osteoporosis), c for 1-3 groups (normal vs osteoporosis), where 0 means
that the two group averages are not statistically significant (p ≥ 0.05)
and 1 means that they are significant (p < 0.05).
As aforementioned, observing the table 7.1 the mean values
of T ⋆2 , T2, ADC and Gi variables are statistically significant among the
three bone density groups (that is a 111 discrimination code) only in
AT region for T ⋆2 and Gi, in ST region for ADC and Gi, in CC and
CALCA regions for T ⋆2 ; in particular, Gi variable assessed in ST region
turns out to be the best site-parameter to discriminate among the three
bone density groups with a p < 0.001 between normal and osteopenic
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Site-Parameter p value p value p value Discrimination code
(1 vs 2) (2 vs 3) (1 vs 3) 1-2-3
T-score ∗ ∗ ∗ ∗ ∗ ∗ ∗ ∗ ∗ 111
Age ns ∗∗ ∗∗ 011
Mfc ns ns ns 000
AC-T⋆
2
ns ∗∗ ∗∗ 011
AC-T2 ns ns ns 000
AC-ADC ns ns ∗∗ 001
AC-Gi ns ∗ ∗∗ 011
AT-T⋆
2
∗ ∗∗ ∗ ∗ ∗ 111
AT-T2 ns ns ns 000
AT-ADC ns ∗ ∗∗ 011
AT-Gi ∗∗ ∗ ∗ ∗ ∗ 111
ST-T⋆
2
ns ∗ ∗ ∗ ∗ ∗ ∗ 011
ST-T2 ns ns ns 000
ST-ADC ∗ ∗∗ ∗ ∗ ∗ 111
ST-Gi ∗ ∗ ∗ ∗∗ ∗ ∗ ∗ 111
TC-T⋆
2
ns ns ∗ 001
TC-T2 ns ns ns 000
TC-ADC ns ∗ ∗ 011
TC-Gi ns ns ∗ 001
CC-T⋆
2
∗ ∗∗ ∗∗ 111
CC-T2 ns ns ns 000
CC-ADC ns ∗ ∗ ∗ ∗∗ 011
CC-Gi ns ns ∗ 001
CALCA-T⋆
2
∗∗ ∗ ∗ ∗ ∗ 111
CALCA-T2 ns ns ns 000
CALCA-ADC ns ∗∗ ∗ ∗ ∗ 011
CALCA-Gi ns ∗ ∗∗ 011
Table 7.1: The discrimination codes, achieved by the comparisons of
the mean values of T -score, Age, Mfc, T ⋆2 , T2, ADC and Gi variables
among the three bone density groups, by p values obtained with the
one-way analysis of variance test, are reported for each investigated
region. Notes: 1. 1 (Normal); 2 (Osteopenia); 3 (Osteoporosis); 2. ns
(p ≥ 0.05); ∗ (p < 0.05); ∗∗ (p < 0.01); ∗ ∗ ∗ (p < 0.001); 3. AC (the
talar region close to calcaneus); AT (the whole talus); ST (the subtalar
region of calcaneus); TC (the tuber calcanei region); CC (the cavum
calcanei region); CALCA (the whole calcaneus); 4. 0 means that the
two averages are not statistically significant, 1 means that they are.
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and between normal and osteoporotic groups and a p < 0.01 between
osteopenic and osteoporotic groups.
Analyzing only the couple comparisons of the groups, T ⋆2 values from
ST region and ADC values from CC region allow a better discrimina-
tion between osteopenic and osteoporotic subjects (p < 0.001), while Gi
values from ST region, as just asserted, allow a better discrimination
between normal and osteopenic subjects (p < 0.001).
If we investigate the ANOVA results for each variable, indepen-
dently from the analyzed regions, we can see in table 7.2 that T ⋆2 has
the highest absolute discrimination percentage (50%, that corresponds
to have the 111 discrimination code in three regions among the six ana-
lyzed regions), the highest normal-osteopenia discrimination percentage
(50%, that corresponds to have the 1bc discrimination code in three
regions among the six analyzed regions), the highest or the highest ex-
aequo osteopenia-osteoporosis discrimination percentage (83.3%, that
corresponds to have the a1c discrimination code in five regions among
the six analyzed regions), the highest or the highest ex-aequo normal-
osteoporosis discrimination percentage (100%, that corresponds to have
the ab1 discrimination code in six regions among the six analyzed re-
gions).
If we instead analyze the ANOVA results for each region, independently
(%) T⋆
2
T2 ADC Gi
Absolute discrimination 50.0 0.0 16.7 33.3
Discrimination 1-2 50.0 0.0 16.7 33.3
Discrimination 2-3 83.3 0.0 83.3 66.7
Discrimination 1-3 100.0 0.0 100.0 100.0
Table 7.2: ANOVA results for each variable, independently from the an-
alyzed regions: absolute discrimination percentage; normal-osteopenia
(1-2) discrimination percentage; osteopenia-osteoporosis (2-3) discrimi-
nation percentage; normal-osteoporosis (1-3) discrimination percentage.
from the analyzed parameters, we can see in table 7.3 that AT and ST
regions have the highest absolute discrimination percentage (50%, that
corresponds to have the 111 discrimination code for two parameters
among the four analyzed parameters), the highest normal-osteopenia
132 Chapter 7: The best Site-Parameter
(%) AC AT ST TC CC CALCA
Absolute discrimination 0.0 50.0 50.0 0.0 25.0 25.0
Discrimination 1-2 0.0 50.0 50.0 0.0 25.0 25.0
Discrimination 2-3 50.0 75.0 75.0 25.0 50.0 75.0
Discrimination 1-3 75.0 75.0 75.0 75.0 75.0 75.0
Table 7.3: ANOVA results for each region, independently from the
analyzed parameters: absolute discrimination percentage; normal-
osteopenia (1-2) discrimination percentage; osteopenia-osteoporosis (2-
3) discrimination percentage; normal-osteoporosis (1-3) discrimination
percentage.
discrimination percentage (50%, that corresponds to have the 1bc dis-
crimination code for two parameters among the four analyzed param-
eters), the highest or the highest ex-aequo osteopenia-osteoporosis dis-
crimination percentage (75%, that corresponds to have the a1c discrim-
ination code for three parameters among the four analyzed parameters),
the highest or the highest ex-aequo normal-osteoporosis discrimination
percentage (75%, that corresponds to have the ab1 discrimination code
for three parameters among the four analyzed parameters).
7.2 Classification indexes
To identify the site-parameter couple which best classifies the
subjects in the same way of T -score, we use the classification indexes.
Nevertheless, contrary to T -score with its cut-off values defined by
WHO, we haven’t any standardized threshold values for each investi-
gated parameter by which discriminate the subjects among the three
bone density groups, by using the parameter value. However, it is pos-
sible to make some considerations.
Let’s order the subjects by T -score decreasing values and define their
classification basing on T -score values, then, considering a region of
analysis, let’s order the same subjects by parameter increasing or de-
creasing values, in accord with the trends outlined by the ranking pa-
rameter in tables 5.1 and 6.4 or by theoretical forecasts for no ranking
cases (for example by Gi decreasing values or by T2 increasing values).
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It’s not senseless to assert that if T -score and the analyzed parame-
ter misure similar something, it’s possible to redefine the classification
of the subjects basing on parameter values, taking into account that
the first 12 are normal, the second 37 are osteopenic, and the last 28
are osteoporotic subjects. Thus, every subject will have two classifica-
tions: by T -score value and by parameter value. Now, let’s consider the
first one method (T -score) like true (’gold standard’) and the second
one method (parameter) to test. By creating a 3x3 matching matrix,
it’s possible to calculate the classification indexes, that are the accord
percentage between the two kinds of classifications (% accord) and, for
every group, the sensibility (Sens), the specificity (Spec) and the posi-
tive (PV+1) and negative (PV -1) predictive value of the classification
method to test; in each group, the sensibility and the specificity will
have the same values of the positive predictive value and of the negative
predictive value respectively, because, as defined, the number of normal,
osteopenic and osteoporotic subjects are the same for the two methods.
Let’s perform this procedure to calculate the classification indexes for
Age, Mfc, T ⋆2 , T2, ADC and Gi parameters in every analyzed region.
From graphs in Fig. 7.1 and 7.2 of the obtained results, we
can notice that the sensibility and the positive predictive value for nor-
mal subjects show the highest variableness in every region, among the
analyzed parameters; in particular, Gi parameter almost always shows
the highest sensibility and positive predictive value for normal subjects.
Grouping in table 7.4 the highest index values and the relative
site-parameter couples, we can see that the highest and considerable ac-
cord percentage (62.96%) with T -score method was obtained with AT -
Gi couple; the highest sensibility (62.50%), specificity (93.62%), positive
and negative predictive values to detect the normal subjects were ob-
tained with ST -Gi couple; the highest sensibility (60.00% for osteopenic
and 68.18% for osteoporotic subjects), specificity (66.67% for osteopenic
and 78.79% for osteoporotic subjects), positive and negative predictive
values to detect the osteopenic and to detect the osteoporotic subjects
were obtained with CC-ADC couple.
The maximum and very high specificity and negative predic-
tive value (93.62%), among the three groups, were obtained with ST -Gi
couple for normal subjects; thus Gi quantification from the subtalar
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Classification index Maximum value (%) Site-Parameter
% accord 62.96 AT-Gi -
Sens1 62.50 AT-Gi ST-Gi
Sens2 60.00 AT-Gi CC-ADC
Sens3 68.18 CC-ADC -
Spec1 93.62 ST-Gi -
Spec2 66.67 CC-ADC -
Spec3 78.79 AT-Gi CC-ADC
PV+1 62.50 AT-Gi ST-Gi
PV-1 93.62 ST-Gi -
PV+2 60.00 AT-Gi CC-ADC
PV-2 66.67 CC-ADC -
PV+3 68.18 CC-ADC -
PV-3 78.79 AT-Gi CC-ADC
Table 7.4: The highest index percentage values and the relative site-
parameter couples are reported. Notes: 1. 1 (Normal); 2 (Osteopenia);
3 (Osteoporosis); 2. Sens (sensibility); Spec (specificity); PV+ (positive
predictive value); PV- (negative predictive value); 3. AT (the whole
talus); ST (the subtalar region of calcaneus); CC (the cavum calcanei
region).
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region of calcaneus might represent a non invasive screening investiga-
tion to identify those subjects for whom a further bone mineral density
assessment, by X-ray techniques, is indicated. Indeed, for example, if
this quantification identifies an individual as a not normal subject, there
will be a probability of about 94% that the individual really will be an
osteopenic or osteoporotic subject.
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Figure 7.1: For AC, AT and CALCA regions, the classification indexes
of Age, Mfc, T ⋆2 , T2, ADC and Gi parameters are reported: the accord
percentage between the two kinds of classifications (% accord) and, for
every group, the sensibility (Sens), the specificity (Spec) and the posi-
tive (PV+1) and negative (PV -1) predictive value of the classification
method to test.
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Figure 7.2: For ST , TC and CC regions, the classification indexes of
Age, Mfc, T ⋆2 , T2, ADC and Gi parameters are reported: the accord
percentage between the two kinds of classifications (% accord) and, for
every group, the sensibility (Sens), the specificity (Spec) and the posi-
tive (PV+1) and negative (PV -1) predictive value of the classification
method to test.

Conclusions
In the present work, the whole experimental results are or-
ganized into three chapters, corresponding to three connected research
lines, and into a last chapter of analysis and comparison of the results
obtained in the first three chapters. This study used quantitative MR
techniques at 3T to investigate spongy bone tissue of postmenopausal
women in different heel locations: the whole calcaneus (CALCA), the
whole talus (AT ), the talar region close to calcaneus AC, the subtalar
region of calcaneus ST, the tuber calcanei region TC and the cavum
calcanei region CC. The choice of the heel was mainly due to three rea-
sons: the established correlation between vertebral body fracture and
poor trabecular bone density in calcaneus spongy bone, the high het-
erogeneity of the trabecular bone network in calcaneus and talus and
the negligible problems linked to claustrophobic symptoms.
The first chapter gives information about the marrow fat con-
tent in calcaneus, by means of 1H Magnetic Resonance Spectroscopy
measures; Mfc ranges in a small gap (from about 80% to 94%) that
hampers to point out the probable skill of Mfc to detect bone den-
sity changes. Moreover, in this situation it’s very hard to discriminate
the little compensatory filling of the inter-trabecular spaces created by
osteoporosis with fatty marrow, from the high marrow fat content of
calcaneus.
The results regarding marrow water molecular diffusion anal-
ysis, reported in the second chapter, show that the mean ADC values
of the three bone density groups (normal, osteopenia and osteoporosis)
increase as bone density decreases but these differences are statistically
significant between the three groups only in subtalar region of calca-
neus. These mean ADC values are one order of magnitude lower than
those reported in previous studies analyzing vertebrae; this difference is
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due to higher marrow fat content in calcaneus than in vertebra, which
restricts the water molecular diffusion.
Our ADC results agree with literature findings at low or intermediate
marrow fat content (20%-60%), for the statistically significant negative
correlation between ADC and T -score values. Conversely, ADC results
disagree with literature findings at intermediate-high marrow fat con-
tent (45%-80%), for the opposite trend of mean ADC values obtained
with bone density changes. These different trends can be ascribed to
the different marrow fat contents analyzed. Thus, resuming also the
literature findings, we can assert that when low or intermediate mar-
row fat content occurs, water molecules are restricted by the trabecular
bone rather than fat cells, thus the change in ADC value depends on
the trabecular bone architecture. Conversely, when intermediate or high
marrow fat content occurs, water molecules are more restricted by the
fat cell concentration than by trabecular bone. For very high marrow
fat content (80%-94%), as in saturation condition, ADC parameter be-
comes again sensible to the intertrabecular spaces created by trabecular
bone density decreasing.
The third chapter gives information about parameters related
to NMR Relaxometry (T ⋆2 and T2) and to a new MR parameter (the
internal gradient Gi) that we demonstrate to be strictly associated with
trabecular bone density and structural rearrangements.
In vitro experiments on calf spongy-bone samples (extracted from a
femur head) showed a high positive linear correlation between water
Gi and trabecular bone density. Moreover, water ADC increases with
the decrease in trabecular bone density at low/moderate Mfc. Finally,
these in vitro experiments demonstrated that in the central zone of each
pore there is a higher concentration of fat molecules, due to their hy-
drophobic nature, characterized by a lower molecular motion than that
of water molecules, while water molecules wet the surface of bone pores.
The results of in vivo experiments show that the mean T ⋆2 values (which
agree with literature findings) of the three bone density groups increase
as bone density decreases and these differences are statistically signif-
icant between the three groups in AT, CC and CALCA regions; the
mean T2 values have no trend as bone density decreases, probably due
to the poor dependence of the T2 parameter on the Gi and ADC fac-
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tors; the mean Gi values of the three bone density groups decrease as
bone density decreases and these differences are statistically significant
among the three groups only in AT and ST regions.
Mean T ⋆2 and Gi values also differ, in each group, among calcaneal re-
gions with different trabecular bone density, thus these parameters give
us information on local trabecular bone density. By their values, they
moreover locate higher trabecular bone density in the whole talus than
in the whole calcaneus and, instead, higher trabecular bone density in
ST than in AC region.
Even if ADC and Gi parameters are able to distinguish the
three bone density groups, according to WHO criteria, they have a low
or moderate significant correlation with T -score values and this demon-
strates that they don’t depend only on the bone density but also on
other factors bound to the bone quality. Mean ADC values of the three
bone density groups overlap when considering their SDs; the mean Gi
values almost always have the same behavior, only its values of the nor-
mal and osteoporotic groups in ST region don’t overlap. Thus, the large
standard deviation associated with mean ADC and Gi values assessed
in spongy bone tissue from healthy, osteopenic and osteoporotic individ-
uals does not allow the clinical use of ADC and Gi on a single subject
basis. Nevertheless, taking into consideration the whole calcaneus and
its regions only, in which it was evaluated the Mfc, it is possible to
notice that in the graphs of the ADC and Gi values versus Mfc val-
ues, the straight lines of the three bone density groups, obtained by the
linear regression analysis, tend to a common intermediate ADC and Gi
value respectively, at highest Mfc values. Thus, we can assert that the
marrow fat content evaluation might improve the diagnostic confidence
of osteoporosis, by ADC and Gi assessment of the calcaneal regions in
subjects with lowest Mfc values.
Finally, in the last chapter we identify the site-parameter cou-
ples which best classify the subjects in the same way of T -score, through
the classification indexes. The highest sensibility (62.50%), specificity
(93.62%), positive and negative predictive values to detect the nor-
mal subjects were obtained with ST -Gi couple; the highest sensibility
(60.00% for osteopenic and 68.18% for osteoporotic subjects), specificity
(66.67% for osteopenic and 78.79% for osteoporotic subjects), positive
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and negative predictive values to detect the osteopenic and to detect
the osteoporotic subjects were obtained with CC-ADC couple.
In all these results, Gi seems to be a potential surrogate marker
reflecting different structural features of trabecular bone density. They
include not only the solid phase density, but also other characteristics
related to spongy bone quality (as expressed by marrow fat content).
Analyzing the future developments of this work, Gi quantifica-
tion from the subtalar region of calcaneus might represent a non inva-
sive screening investigation to identify those subjects for whom a further
bone mineral density assessment, by X-ray techniques, is indicated.
Measures of T ⋆2 , ADC, and Gi from the ST and CC calcaneal regions
(as a function of the bone marrow fat content) obtained on large pop-
ulations, could allow the definition of their cut-off values for normality
and osteopenia.
Through analysis of many clinical risk factors, it’ll be possible to make
new definitions of the osteoporosis general diagnostic categories for wo-
men and men, based on the value of a parameter opportunely related
to the values of T ⋆2 , ADC, Gi and Mfc parameters, and also to obtain
a graph of the values of this new parameter versus the age, by which
it’ll be easy to classify the person with respect to the age (New Gold
Standard).
This innovative method will be more effective than the current
diagnostic methods, because it is a not invasive technique that includes
quantitative information about trabecular bone density by MR relax-
ometry and information on the physiological and functional changes by
MR spectroscopy and water diffusion in bone marrow, connected with
fracture risk factor.
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